TOC


Please note: A selected table may take a few minutes to load.

260521
Table 5.1A – Substance Use Disorder for Specific Substances in Past Year: Among People Aged 12 or Older; by Age Group, Numbers in Thousands, 2024 and 2025
Substance Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
SUBSTANCE USE DISORDER 48,351b 44,576 2,024 1,877 46,327b 42,699 9,056 8,577 37,271a 34,121
DRUGS 28,184a 25,969 1,705 1,511 26,480a 24,458 6,210 5,723 20,269 18,735
Marijuana 20,585 19,338 1,219 1,118 19,366 18,220 5,536 5,089 13,830 13,132
Cocaine 1,211 1,408 14 12 1,197 1,396 280 224 917 1,171
Heroin 496 477 9 <1 486 477 33b 4 453 473
Hallucinogens 433 495 83 66 350 430 102 129 248 300
Inhalants 352 257 84 90 269 167 82a 28 187 139
Methamphetamine 1,571 1,807 9 3 1,562 1,804 96 85 1,465 1,719
Prescription Psychotherapeutics 7,628a 6,428 524 426 7,104a 6,003 805 775 6,300a 5,228
Pain Relievers 4,952a 3,945 286 227 4,666a 3,718 341 351 4,325a 3,367
Prescription Opioids 4,596a 3,709 262 207 4,334a 3,502 314 335 4,020a 3,167
Stimulants 1,846 1,722 191 208 1,655 1,514 411 352 1,243 1,162
Tranquilizers or Sedatives 2,096 1,679 119a 62 1,976 1,617 239 235 1,737 1,382
Tranquilizers 1,497 1,368 84b 25 1,413 1,343 194 176 1,219 1,167
Sedatives 812a 482 44 44 767a 438 90 74 677a 364
Opioids 4,822a 3,972 267 207 4,555a 3,764 335 337 4,220a 3,427
Central Nervous System Stimulants 4,266 4,493 210 213 4,056 4,280 722 591 3,334 3,689
ALCOHOL 27,913a 25,746 775 710 27,138a 25,036 5,029 4,731 22,108a 20,304
BOTH DRUGS AND ALCOHOL 7,746 7,139 456 344 7,290 6,795 2,183 1,877 5,106 4,918
DRUGS ONLY (NO ALCOHOL USE DISORDER) 20,438 18,830 1,249 1,167 19,190 17,663 4,027 3,846 15,163 13,817
ALCOHOL ONLY (NO DRUG USE DISORDER) 20,167 18,607 319 366 19,848a 18,241 2,846 2,854 17,002a 15,387
NO SUBSTANCE USE DISORDER 239,891 245,942 23,928 23,578 215,964 222,364 25,890 27,516 190,074 194,848

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.1B – Substance Use Disorder for Specific Substances in Past Year: Among People Aged 12 or Older; by Age Group, Percentages, 2024 and 2025
Substance Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
SUBSTANCE USE DISORDER 16.8b 15.3 7.8 7.4 17.7b 16.1 25.9a 23.8 16.4b 14.9
DRUGS 9.8b 8.9 6.6 5.9 10.1a 9.2 17.8b 15.9 8.9a 8.2
Marijuana 7.1 6.7 4.7 4.4 7.4 6.9 15.8a 14.1 6.1 5.7
Cocaine 0.4 0.5 0.1 <0.1 0.5 0.5 0.8 0.6 0.4 0.5
Heroin 0.2 0.2 <0.1 <0.1 0.2 0.2 0.1b <0.1 0.2 0.2
Hallucinogens 0.2 0.2 0.3 0.3 0.1 0.2 0.3 0.4 0.1 0.1
Inhalants 0.1 0.1 0.3 0.4 0.1 0.1 0.2a 0.1 0.1 0.1
Methamphetamine 0.5 0.6 <0.1 <0.1 0.6 0.7 0.3 0.2 0.6 0.8
Prescription Psychotherapeutics 2.6b 2.2 2.0 1.7 2.7a 2.3 2.3 2.1 2.8a 2.3
Pain Relievers 1.7b 1.4 1.1 0.9 1.8b 1.4 1.0 1.0 1.9b 1.5
Prescription Opioids 1.6a 1.3 1.0 0.8 1.7a 1.3 0.9 0.9 1.8a 1.4
Stimulants 0.6 0.6 0.7 0.8 0.6 0.6 1.2 1.0 0.5 0.5
Tranquilizers or Sedatives 0.7 0.6 0.5a 0.2 0.8 0.6 0.7 0.7 0.8 0.6
Tranquilizers 0.5 0.5 0.3b 0.1 0.5 0.5 0.6 0.5 0.5 0.5
Sedatives 0.3a 0.2 0.2 0.2 0.3b 0.2 0.3 0.2 0.3a 0.2
Opioids 1.7a 1.4 1.0 0.8 1.7a 1.4 1.0 0.9 1.9a 1.5
Central Nervous System Stimulants 1.5 1.5 0.8 0.8 1.5 1.6 2.1 1.6 1.5 1.6
ALCOHOL 9.7b 8.9 3.0 2.8 10.3b 9.4 14.4a 13.1 9.7a 8.9
BOTH DRUGS AND ALCOHOL 2.7 2.5 1.8 1.4 2.8 2.6 6.2a 5.2 2.2 2.1
DRUGS ONLY (NO ALCOHOL USE DISORDER) 7.1a 6.5 4.8 4.6 7.3a 6.7 11.5 10.7 6.7a 6.0
ALCOHOL ONLY (NO DRUG USE DISORDER) 7.0a 6.4 1.2 1.4 7.6a 6.9 8.1 7.9 7.5a 6.7
NO SUBSTANCE USE DISORDER 83.2b 84.7 92.2 92.6 82.3b 83.9 74.1a 76.2 83.6b 85.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.2A – Substance Use Disorder Severity Level for Specific Substances in Past Year: Among People Aged 12 or Older; Numbers in Thousands, 2024 and 2025
Substance Any Substance Use Disorder
(2024)		 Any Substance Use Disorder
(2025)		 Severity Level
Mild Substance Use Disorder
(2024)		 Mild Substance Use Disorder
(2025)		 Moderate Substance Use Disorder
(2024)		 Moderate Substance Use Disorder
(2025)		 Severe Substance Use Disorder
(2024)		 Severe Substance Use Disorder
(2025)
SUBSTANCE USE DISORDER 48,351b 44,576 27,001b 24,102 11,031 10,444 10,319 10,030
DRUGS 28,184a 25,969 15,508a 13,751 6,881 6,484 5,795 5,734
Marijuana 20,585 19,338 11,188 10,328 5,747 5,535 3,650 3,475
Cocaine 1,211 1,408 498 534 257 297 457 577
Heroin 496 477 66 22 83 66 347 389
Hallucinogens 433 495 291 334 99 94 42 68
Inhalants 352 257 209 157 72 56 71 44
Methamphetamine 1,571 1,807 257 375 307 391 1,006 1,042
Prescription Psychotherapeutics 7,628a 6,428 5,330a 4,321 1,214 1,131 1,084 976
Pain Relievers 4,952a 3,945 3,509b 2,531 710 866 734 548
Prescription Opioids 4,596a 3,709 3,193b 2,345 681 830 722 534
Stimulants 1,846 1,722 1,208 1,134 375 325 263 263
Tranquilizers or Sedatives 2,096 1,679 1,406 1,164 308a 166 382 349
Tranquilizers 1,497 1,368 942 956 229a 116 326 296
Sedatives 812a 482 546a 319 154 88 112 75
Opioids 4,822a 3,972 3,152b 2,338 738 827 932 806
Central Nervous System Stimulants 4,266 4,493 1,781 1,830 871 908 1,613 1,756
ALCOHOL 27,913a 25,746 16,567a 14,834 5,975 5,593 5,370 5,319

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.2B – Substance Use Disorder Severity Level for Specific Substances in Past Year: Among People Aged 12 or Older; Percentages, 2024 and 2025
Substance Any Substance Use Disorder
(2024)		 Any Substance Use Disorder
(2025)		 Severity Level
Mild Substance Use Disorder
(2024)		 Mild Substance Use Disorder
(2025)		 Moderate Substance Use Disorder
(2024)		 Moderate Substance Use Disorder
(2025)		 Severe Substance Use Disorder
(2024)		 Severe Substance Use Disorder
(2025)
SUBSTANCE USE DISORDER 16.8b 15.3 9.4b 8.3 3.8 3.6 3.6 3.5
DRUGS 9.8b 8.9 5.4b 4.7 2.4 2.2 2.0 2.0
Marijuana 7.1 6.7 3.9 3.6 2.0 1.9 1.3 1.2
Cocaine 0.4 0.5 0.2 0.2 0.1 0.1 0.2 0.2
Heroin 0.2 0.2 <0.1 <0.1 <0.1 <0.1 0.1 0.1
Hallucinogens 0.2 0.2 0.1 0.1 <0.1 <0.1 <0.1 <0.1
Inhalants 0.1 0.1 0.1 0.1 <0.1 <0.1 <0.1 <0.1
Methamphetamine 0.5 0.6 0.1 0.1 0.1 0.1 0.3 0.4
Prescription Psychotherapeutics 2.6b 2.2 1.8a 1.5 0.4 0.4 0.4 0.3
Pain Relievers 1.7b 1.4 1.2b 0.9 0.2 0.3 0.3 0.2
Prescription Opioids 1.6a 1.3 1.1b 0.8 0.2 0.3 0.3 0.2
Stimulants 0.6 0.6 0.4 0.4 0.1 0.1 0.1 0.1
Tranquilizers or Sedatives 0.7 0.6 0.5 0.4 0.1a 0.1 0.1 0.1
Tranquilizers 0.5 0.5 0.3 0.3 0.1a <0.1 0.1 0.1
Sedatives 0.3a 0.2 0.2a 0.1 0.1 <0.1 <0.1 <0.1
Opioids 1.7a 1.4 1.1b 0.8 0.3 0.3 0.3 0.3
Central Nervous System Stimulants 1.5 1.5 0.6 0.6 0.3 0.3 0.6 0.6
ALCOHOL 9.7b 8.9 5.7b 5.1 2.1 1.9 1.9 1.8

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.3A – Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2024 and 2025
Age Category Drug Use Disorder
(2024)		 Drug Use Disorder
(2025)		 Alcohol Use Disorder
(2024)		 Alcohol Use Disorder
(2025)		 Substance Use Disorder
(2024)		 Substance Use Disorder
(2025)
TOTAL 28,184a 25,969 27,913a 25,746 48,351b 44,576
12‑20 3,654 3,337 1,998 2,039 4,627 4,532
21 or Older 24,530 22,631 25,915a 23,707 43,724b 40,043
12‑17 1,705 1,511 775 710 2,024 1,877
12‑13 212 199 55 66 238 234
14‑15 468 502 212 190 550 601
16‑17 1,025a 810 509 454 1,235 1,042
18 or Older 26,480a 24,458 27,138a 25,036 46,327b 42,699
18‑25 6,210 5,723 5,029 4,731 9,056 8,577
18‑20 1,949 1,826 1,223 1,329 2,603 2,655
21‑25 4,261 3,897 3,807 3,402 6,453 5,922
26 or Older 20,269 18,735 22,108a 20,304 37,271a 34,121
26‑49 13,498 12,481 13,768 12,673 23,469a 21,432
26‑29 3,161 2,710 2,635 2,673 4,882 4,446
30‑34 3,263 3,263 3,118 2,883 5,417 5,218
35‑39 2,931 2,614 3,169 2,666 5,234a 4,517
40‑44 2,178 2,171 2,700 2,531 4,281 4,080
45‑49 1,966 1,724 2,146 1,920 3,654 3,170
50 or Older 6,771 6,253 8,340 7,632 13,802 12,690
50‑54 1,607 1,616 1,797 1,267 2,964 2,607
55‑59 1,389 1,443 1,875 1,822 3,007 2,861
60‑64 1,506 1,304 1,778 1,800 3,021 2,937
65 or Older 2,270 1,890 2,890 2,743 4,809 4,284

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.3B – Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2024 and 2025
Age Category Drug Use Disorder
(2024)		 Drug Use Disorder
(2025)		 Alcohol Use Disorder
(2024)		 Alcohol Use Disorder
(2025)		 Substance Use Disorder
(2024)		 Substance Use Disorder
(2025)
TOTAL 9.8b 8.9 9.7b 8.9 16.8b 15.3
12‑20 9.5a 8.5 5.2 5.2 12.0 11.6
21 or Older 9.8a 9.0 10.4b 9.4 17.5b 15.9
12‑17 6.6 5.9 3.0 2.8 7.8 7.4
12‑13 2.6 2.5 0.7 0.8 2.9 3.0
14‑15 5.3 5.8 2.4 2.2 6.2 6.9
16‑17 11.4a 9.1 5.7 5.1 13.7 11.7
18 or Older 10.1a 9.2 10.3b 9.4 17.7b 16.1
18‑25 17.8b 15.9 14.4a 13.1 25.9a 23.8
18‑20 15.5a 13.2 9.7 9.6 20.7 19.3
21‑25 19.0 17.5 17.0a 15.3 28.8a 26.5
26 or Older 8.9a 8.2 9.7a 8.9 16.4b 14.9
26‑49 12.8 11.8 13.0 12.0 22.2b 20.3
26‑29 18.1 15.7 15.1 15.5 27.9 25.8
30‑34 13.9 13.9 13.3 12.3 23.0 22.3
35‑39 12.7 11.6 13.7 11.8 22.6 20.1
40‑44 9.7 9.9 12.0 11.5 19.1 18.6
45‑49 10.2 8.5 11.1 9.5 19.0a 15.7
50 or Older 5.6 5.1 6.9 6.2 11.4 10.3
50‑54 8.2 8.9 9.1 7.0 15.0 14.4
55‑59 7.1 7.4 9.6 9.3 15.4 14.6
60‑64 6.7 5.7 7.9 7.9 13.4 12.9
65 or Older 3.8 3.0 4.8 4.3 8.0 6.8

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.4A – Drug Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
TOTAL 28,184a 25,969 1,705 1,511 26,480a 24,458 6,210 5,723 20,269 18,735
SEX                    
Male 16,092a 14,288 736 736 15,356a 13,552 3,315 3,112 12,041a 10,441
Female 12,093 11,680 969a 775 11,124 10,905 2,896 2,611 8,228 8,294
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 23,338b 20,846 1,243 1,040 22,095a 19,806 4,779a 4,220 17,316a 15,586
AIAN 207 274 13 20 195 254 45 33 150 221
Asian 726 614 57 23 669 591 162 149 507 442
Black or African American 3,979 3,732 246 280 3,733 3,453 961 824 2,772 2,628
NHPI 66 107 1 * 65 106 * * 48 *
White 17,245b 14,741 843a 628 16,402b 14,113 3,322a 2,820 13,080a 11,293
Two or More Races 1,115 1,377 84 88 1,030 1,289 273 368 757 921
Hispanic or Latino 4,846 5,123 462 471 4,384 4,652 1,431 1,503 2,953 3,148
EDUCATION LEVEL                    
< High School da da da da 2,851 2,917 714 664 2,137 2,253
High School Graduate da da da da 8,794 8,045 2,227 2,290 6,567 5,754
Some College/Associate’s Degree da da da da 9,339b 8,007 2,430a 2,000 6,909 6,006
College Graduate da da da da 5,496 5,489 840 768 4,656 4,721
EMPLOYMENT STATUS                    
Full‑Time da da da da 11,633 10,896 2,703 2,368 8,929 8,528
Part‑Time da da da da 3,700 3,872 1,477 1,466 2,223 2,406
Unemployed da da da da 2,447 2,362 817 797 1,631 1,565
Other1 da da da da 8,700a 7,328 1,214 1,092 7,486a 6,236

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Drug use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on drug use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.4B – Drug Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
TOTAL 9.8b 8.9 6.6 5.9 10.1a 9.2 17.8b 15.9 8.9a 8.2
SEX                    
Male 11.4b 10.2 5.5 5.7 12.0b 10.6 18.9 17.1 10.9a 9.5
Female 8.2 7.8 7.6a 6.2 8.3 7.9 16.7a 14.6 7.0 6.9
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 10.0b 8.9 6.5 5.6 10.3b 9.2 18.3b 15.9 9.2a 8.3
AIAN 15.2 14.8 6.0 7.5 16.9 16.1 28.7 15.8 15.0 16.1
Asian 3.9 3.2 3.8 1.5 3.9 3.3 6.7 5.9 3.4 2.9
Black or African American 11.3 10.8 6.9 8.2 11.8 11.1 20.9 17.7 10.2 9.9
NHPI 5.3 10.1 0.7 * 5.6 10.6 * * 4.8 *
White 10.1b 8.8 6.7a 5.2 10.4b 9.1 18.7b 16.2 9.3a 8.2
Two or More Races 17.2 14.6 8.1 6.6 18.9 15.9 23.8 21.6 17.6 14.3
Hispanic or Latino 8.9 9.1 6.7 6.9 9.2 9.4 16.3 15.8 7.6 7.8
EDUCATION LEVEL                    
< High School da da da da 11.9 11.9 20.2 17.9 10.4 10.9
High School Graduate da da da da 12.5 11.3 18.3 17.8 11.3 9.9
Some College/Associate’s Degree da da da da 12.0b 10.4 18.3b 15.0 10.7 9.4
College Graduate da da da da 6.1 5.9 14.0 12.4 5.5 5.5
EMPLOYMENT STATUS                    
Full‑Time da da da da 9.6 9.2 19.3 17.3 8.3 8.2
Part‑Time da da da da 11.4 11.1 16.8 15.2 9.4 9.5
Unemployed da da da da 19.0 17.2 22.2 19.5 17.7 16.3
Other1 da da da da 9.1b 7.4 14.4 12.6 8.6b 6.9

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Drug use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on drug use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.5A – Marijuana Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
TOTAL 20,585 19,338 1,219 1,118 19,366 18,220 5,536 5,089 13,830 13,132
SEX                    
Male 12,389a 11,116 514 561 11,875a 10,555 3,005 2,807 8,869a 7,749
Female 8,196 8,221 705 557 7,491 7,665 2,531 2,282 4,961 5,383
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 17,068a 15,477 862 730 16,206a 14,747 4,261 3,816 11,944 10,931
AIAN 171 180 9 17 162 163 38 23 124 140
Asian 410 286 26 8 384 278 138 119 246 159
Black or African American 3,398 3,169 177 220 3,222 2,950 904 765 2,318 2,184
NHPI 55 83 1 * 54 83 * * * *
White 12,168a 10,689 587a 421 11,581a 10,268 2,911 2,558 8,670 7,711
Two or More Races 866 1,070 63 65 803 1,005 256 326 547 679
Hispanic or Latino 3,517 3,860 357 387 3,161 3,473 1,275 1,272 1,886 2,201
EDUCATION LEVEL                    
< High School da da da da 1,921 2,095 631 590 1,290 1,504
High School Graduate da da da da 6,719 6,227 1,980 2,077 4,739 4,150
Some College/Associate’s Degree da da da da 6,812a 5,963 2,155a 1,720 4,656 4,242
College Graduate da da da da 3,915 3,936 770 700 3,145 3,235
EMPLOYMENT STATUS                    
Full‑Time da da da da 9,494 8,799 2,462 2,214 7,032 6,585
Part‑Time da da da da 2,902 2,851 1,334 1,266 1,567 1,585
Unemployed da da da da 2,009 1,808 738 720 1,270 1,088
Other1 da da da da 4,962 4,762 1,002 889 3,960 3,873

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Marijuana use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on marijuana use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.5B – Marijuana Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
TOTAL 7.1 6.7 4.7 4.4 7.4 6.9 15.8a 14.1 6.1 5.7
SEX                    
Male 8.8a 7.9 3.9 4.3 9.3a 8.3 17.1 15.4 8.1a 7.1
Female 5.6 5.5 5.6 4.5 5.6 5.6 14.6 12.7 4.2 4.5
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 7.3a 6.6 4.5 3.9 7.6a 6.8 16.3a 14.4 6.3 5.8
AIAN 12.5 9.7 4.1 6.2 14.1 10.3 24.6a 11.0 12.4 10.2
Asian 2.2 1.5 1.7 0.5 2.2 1.6 5.8 4.7 1.7 1.0
Black or African American 9.6 9.2 5.0 6.4 10.2 9.5 19.7 16.4 8.6 8.3
NHPI 4.4 7.8 0.7 * 4.7 8.3 * * * *
White 7.1a 6.4 4.6a 3.5 7.3a 6.6 16.4 14.7 6.2 5.6
Two or More Races 13.4 11.3 6.1 4.9 14.8 12.4 22.3 19.1 12.7 10.6
Hispanic or Latino 6.4 6.8 5.2 5.7 6.6 7.0 14.5 13.4 4.8 5.5
EDUCATION LEVEL                    
< High School da da da da 8.0 8.6 17.8 15.9 6.3 7.3
High School Graduate da da da da 9.6 8.8 16.3 16.2 8.1 7.1
Some College/Associate’s Degree da da da da 8.7a 7.7 16.3b 12.9 7.2 6.6
College Graduate da da da da 4.3 4.3 12.9 11.3 3.7 3.8
EMPLOYMENT STATUS                    
Full‑Time da da da da 7.8 7.5 17.5 16.2 6.6 6.3
Part‑Time da da da da 9.0 8.2 15.2 13.1 6.6 6.3
Unemployed da da da da 15.6 13.2 20.1 17.6 13.8 11.3
Other1 da da da da 5.2 4.8 11.9 10.3 4.5 4.3

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Marijuana use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on marijuana use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.6A – Prescription Opioid Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
TOTAL 4,596a 3,709 262 207 4,334a 3,502 314 335 4,020a 3,167
SEX                    
Male 2,218 1,765 80 117 2,138 1,648 130 190 2,008a 1,458
Female 2,378 1,944 182b 90 2,196 1,854 184 146 2,012 1,709
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 3,807a 2,950 189 157 3,618a 2,793 239 214 3,379a 2,579
AIAN 22 35 4 3 19 32 * 8 13 24
Asian 225 207 9 3 216 205 2 19 214 186
Black or African American 428 431 33 27 396 404 45 50 351 354
NHPI 11 * * * 11 * * * 7 *
White 2,955b 2,114 135 112 2,820b 2,002 159 129 2,661b 1,873
Two or More Races 165 138 9 11 156 128 23 8 133 119
Hispanic or Latino 789 759 73 50 716 709 75 121 641 588
EDUCATION LEVEL                    
< High School da da da da 670 622 64 81 605 541
High School Graduate da da da da 1,613 1,242 165 125 1,448 1,116
Some College/Associate’s Degree da da da da 1,464a 1,025 75 113 1,389a 912
College Graduate da da da da 587 613 10 16 577 598
EMPLOYMENT STATUS                    
Full‑Time da da da da 1,005 1,052 73 115 932 937
Part‑Time da da da da 509 331 89 55 420 276
Unemployed da da da da 222 328 47 78 175 250
Other1 da da da da 2,598b 1,791 105 87 2,493a 1,704

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Prescription opioid use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on prescription pain reliever use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.6B – Prescription Opioid Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
TOTAL 1.6a 1.3 1.0 0.8 1.7a 1.3 0.9 0.9 1.8a 1.4
SEX                    
Male 1.6 1.3 0.6 0.9 1.7 1.3 0.7 1.0 1.8a 1.3
Female 1.6 1.3 1.4b 0.7 1.6 1.3 1.1 0.8 1.7 1.4
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1.6a 1.3 1.0 0.8 1.7a 1.3 0.9 0.8 1.8a 1.4
AIAN 1.6 1.9 1.7 1.1 1.6 2.0 * 3.7 1.3 1.8
Asian 1.2 1.1 0.6 0.2 1.3 1.2 0.1 0.7 1.5 1.2
Black or African American 1.2 1.2 0.9 0.8 1.2 1.3 1.0 1.1 1.3 1.3
NHPI 0.9 * * * 1.0 * * * 0.7 *
White 1.7b 1.3 1.1 0.9 1.8b 1.3 0.9 0.7 1.9a 1.4
Two or More Races 2.5 1.5 0.9 0.8 2.9 1.6 2.0 0.5 3.1 1.9
Hispanic or Latino 1.4 1.3 1.1 0.7 1.5 1.4 0.9 1.3 1.6 1.5
EDUCATION LEVEL                    
< High School da da da da 2.8 2.5 1.8 2.2 3.0 2.6
High School Graduate da da da da 2.3 1.8 1.4 1.0 2.5 1.9
Some College/Associate’s Degree da da da da 1.9a 1.3 0.6 0.8 2.1a 1.4
College Graduate da da da da 0.7 0.7 0.2 0.3 0.7 0.7
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.8 0.9 0.5 0.8 0.9 0.9
Part‑Time da da da da 1.6a 0.9 1.0 0.6 1.8 1.1
Unemployed da da da da 1.7 2.4 1.3 1.9 1.9 2.6
Other1 da da da da 2.7b 1.8 1.2 1.0 2.9b 1.9

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Prescription opioid use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on prescription pain reliever use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.7A – Opioid Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
TOTAL 4,822a 3,972 267 207 4,555a 3,764 335 337 4,220a 3,427
SEX                    
Male 2,344 1,935 80 117 2,263 1,818 138 191 2,126 1,627
Female 2,478 2,036 186b 90 2,292 1,946 197 146 2,095 1,800
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 4,006a 3,196 193 157 3,813a 3,039 260 216 3,553a 2,823
AIAN 24 36 4 3 20 33 * 8 15 25
Asian 225 207 9 3 216 205 2 19 214 186
Black or African American 454 483 33 28 421 455 47 50 375 404
NHPI 16 * * * 16 * * * 11 *
White 3,121b 2,288 139 112 2,982a 2,176 178 130 2,805a 2,046
Two or More Races 165 158 9 11 156 147 23 8 133 139
Hispanic or Latino 816 776 73 50 742 726 75 121 667 605
EDUCATION LEVEL                    
< High School da da da da 702 760 64 82 638 679
High School Graduate da da da da 1,718 1,268 180 127 1,538 1,141
Some College/Associate’s Degree da da da da 1,542a 1,120 80 113 1,462a 1,007
College Graduate da da da da 592 616 10 16 582 600
EMPLOYMENT STATUS                    
Full‑Time da da da da 1,042 1,140 79 116 962 1,024
Part‑Time da da da da 518 352 89 55 429 297
Unemployed da da da da 270 346 59 78 211 268
Other1 da da da da 2,726a 1,926 107 88 2,618a 1,838

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Opioid use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on opioid use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.7B – Opioid Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
TOTAL 1.7a 1.4 1.0 0.8 1.7a 1.4 1.0 0.9 1.9a 1.5
SEX                    
Male 1.7 1.4 0.6 0.9 1.8 1.4 0.8 1.0 1.9 1.5
Female 1.7 1.4 1.5b 0.7 1.7 1.4 1.1 0.8 1.8 1.5
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1.7a 1.4 1.0 0.8 1.8a 1.4 1.0 0.8 1.9a 1.5
AIAN 1.8 1.9 1.7 1.1 1.8 2.1 * 3.9 1.5 1.8
Asian 1.2 1.1 0.6 0.2 1.3 1.2 0.1 0.7 1.5 1.2
Black or African American 1.3 1.4 0.9 0.8 1.3 1.5 1.0 1.1 1.4 1.5
NHPI 1.3 * * * 1.4 * * * 1.1 *
White 1.8a 1.4 1.1 0.9 1.9a 1.4 1.0 0.8 2.0a 1.5
Two or More Races 2.5 1.7 0.9 0.8 2.9 1.8 2.0 0.5 3.1 2.2
Hispanic or Latino 1.5 1.4 1.1 0.7 1.6 1.5 0.9 1.3 1.7 1.5
EDUCATION LEVEL                    
< High School da da da da 2.9 3.1 1.8 2.2 3.1 3.3
High School Graduate da da da da 2.4 1.8 1.5 1.0 2.6 2.0
Some College/Associate’s Degree da da da da 2.0a 1.4 0.6 0.8 2.3a 1.6
College Graduate da da da da 0.7 0.7 0.2 0.3 0.7 0.7
EMPLOYMENT STATUS                    
Full‑Time da da da da 0.9 1.0 0.6 0.9 0.9 1.0
Part‑Time da da da da 1.6 1.0 1.0 0.6 1.8 1.2
Unemployed da da da da 2.1 2.5 1.6 1.9 2.3 2.8
Other1 da da da da 2.8b 2.0 1.3 1.0 3.0b 2.0

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Opioid use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on opioid use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.8A – Central Nervous System Stimulant Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
TOTAL 4,266 4,493 210 213 4,056 4,280 722 591 3,334 3,689
SEX                    
Male 2,497 2,670 107 90 2,391 2,580 372 260 2,019 2,319
Female 1,769 1,823 103 123 1,665 1,700 350 331 1,315 1,370
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 3,589 3,390 165 177 3,424 3,213 553 423 2,871 2,790
AIAN 20 87 2 <1 18 87 1 5 17 *
Asian 101 121 22 2 79 119 30 9 49 110
Black or African American 307 346 2 18 305 327 44 30 261 297
NHPI 11 6 * * 11 4 <1 * 11 4
White 2,933 2,627 133 139 2,800 2,487 450 349 2,351 2,138
Two or More Races 216 203 6 15 210 189 28 29 183 159
Hispanic or Latino 677a 1,104 45 37 632a 1,067 169 168 463a 899
EDUCATION LEVEL                    
< High School da da da da 462 624 79 55 383 570
High School Graduate da da da da 1,403 1,101 240 201 1,162 900
Some College/Associate’s Degree da da da da 1,301 1,595 315 216 986a 1,379
College Graduate da da da da 890 960 87 120 802 841
EMPLOYMENT STATUS                    
Full‑Time da da da da 1,663 1,696 310a 200 1,352 1,496
Part‑Time da da da da 579 758 134 178 445 580
Unemployed da da da da 454 489 96 81 358 408
Other1 da da da da 1,360 1,337 182 132 1,178 1,205

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Central nervous system stimulant use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on central nervous system stimulant use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.8B – Central Nervous System Stimulant Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
TOTAL 1.5 1.5 0.8 0.8 1.5 1.6 2.1 1.6 1.5 1.6
SEX                    
Male 1.8 1.9 0.8 0.7 1.9 2.0 2.1a 1.4 1.8 2.1
Female 1.2 1.2 0.8 1.0 1.2 1.2 2.0 1.8 1.1 1.1
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1.5 1.4 0.9 0.9 1.6 1.5 2.1 1.6 1.5 1.5
AIAN 1.5 4.7 0.9 0.1 1.6 5.5 0.8 2.3 1.7 *
Asian 0.5 0.6 1.5 0.2 0.5 0.7 1.3 0.4 0.3 0.7
Black or African American 0.9 1.0 0.1 0.5 1.0 1.1 1.0 0.7 1.0 1.1
NHPI 0.9 0.5 * * 1.0 0.4 <0.1 * 1.1 0.4
White 1.7 1.6 1.1 1.2 1.8 1.6 2.5 2.0 1.7 1.5
Two or More Races 3.3 2.2 0.6 1.1 3.9 2.3 2.4 1.7 4.3 2.5
Hispanic or Latino 1.2a 2.0 0.7 0.5 1.3a 2.1 1.9 1.8 1.2a 2.2
EDUCATION LEVEL                    
< High School da da da da 1.9 2.6 2.2 1.5 1.9 2.8
High School Graduate da da da da 2.0 1.6 2.0 1.6 2.0 1.6
Some College/Associate’s Degree da da da da 1.7 2.1 2.4 1.6 1.5a 2.2
College Graduate da da da da 1.0 1.0 1.5 1.9 1.0 1.0
EMPLOYMENT STATUS                    
Full‑Time da da da da 1.4 1.4 2.2a 1.5 1.3 1.4
Part‑Time da da da da 1.8 2.2 1.5 1.8 1.9 2.3
Unemployed da da da da 3.5 3.6 2.6 2.0 3.9 4.2
Other1 da da da da 1.4 1.4 2.2 1.5 1.3 1.3

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Central nervous system stimulant use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on central nervous system stimulant use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.9A – Alcohol Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)		 Aged 12‑20
(2024)		 Aged 12‑20
(2025)		 Aged 21+
(2024)		 Aged 21+
(2025)
TOTAL 27,913a 25,746 775 710 27,138a 25,036 5,029 4,731 22,108a 20,304 1,998 2,039 25,915a 23,707
SEX                            
Male 16,680 15,437 255 329 16,425 15,107 2,640 2,394 13,785 12,713 891 1,053 15,790 14,384
Female 11,232 10,309 520a 380 10,713 9,929 2,390 2,337 8,323 7,592 1,107 986 10,125 9,323
HISPANIC ORIGIN AND RACE                            
Not Hispanic or Latino 22,926b 20,295 562 465 22,364b 19,831 3,715 3,502 18,648b 16,329 1,473 1,473 21,453b 18,822
AIAN 134 146 3 13 130 134 30 21 100 113 14 17 120 130
Asian 1,029 908 * 16 1,016 892 182 141 834 751 56 53 973 854
Black or African American 3,368 2,967 68 51 3,300 2,916 526 532 2,773 2,384 194 205 3,174 2,761
NHPI 98 78 1 * 97 77 * * 68 * * 1 87 77
White 17,647b 15,183 446 336 17,201b 14,847 2,779 2,584 14,422b 12,263 1,140 1,075 16,507b 14,108
Two or More Races 650a 1,014 31 50 620a 964 169 215 451a 749 57b 121 593a 892
Hispanic or Latino 4,987 5,451 213 245 4,774 5,205 1,314 1,230 3,460 3,976 525 566 4,462 4,884
EDUCATION LEVEL                            
< High School da da da da 1,946 2,195 430 360 1,516 1,835 da da 1,730 2,011
High School Graduate da da da da 6,755 6,250 1,663 1,531 5,092 4,719 da da 6,293 5,706
Some College/Associate’s Degree da da da da 8,880 8,027 1,946 1,883 6,933 6,145 da da 8,334 7,426
College Graduate da da da da 9,557 8,564 989 958 8,568 7,606 da da 9,557 8,564
EMPLOYMENT STATUS                            
Full‑Time da da da da 15,109b 13,219 2,520a 2,088 12,589a 11,131 da da 14,631b 12,863
Part‑Time da da da da 3,497 3,254 1,100 1,181 2,397 2,073 da da 3,129 2,840
Unemployed da da da da 1,890 1,970 531 509 1,359 1,461 da da 1,774 1,777
Other1 da da da da 6,642 6,593 879 953 5,764 5,640 da da 6,381 6,227

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Alcohol use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.9B – Alcohol Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)		 Aged 12‑20
(2024)		 Aged 12‑20
(2025)		 Aged 21+
(2024)		 Aged 21+
(2025)
TOTAL 9.7b 8.9 3.0 2.8 10.3b 9.4 14.4a 13.1 9.7a 8.9 5.2 5.2 10.4b 9.4
SEX                            
Male 11.8 11.0 1.9 2.5 12.9a 11.8 15.0 13.2 12.5 11.6 4.5 5.2 13.0a 11.9
Female 7.6a 6.9 4.1a 3.1 8.0a 7.2 13.7 13.1 7.1 6.4 5.9 5.2 7.9a 7.1
HISPANIC ORIGIN AND RACE                            
Not Hispanic or Latino 9.8b 8.7 3.0 2.5 10.4b 9.2 14.2 13.2 9.9b 8.6 5.2 5.2 10.4b 9.2
AIAN 9.8 7.9 1.6 4.6 11.3 8.5 19.5 10.1 10.0 8.2 5.4 4.3 10.9 8.9
Asian 5.5 4.7 * 1.0 5.9 5.1 7.6 5.6 5.7 5.0 2.3 2.2 6.0 5.1
Black or African American 9.6 8.6 1.9 1.5 10.4 9.4 11.5 11.4 10.2 9.0 3.7 3.9 10.6 9.4
NHPI 7.9 7.3 1.7 * 8.4 7.7 * * 6.7 * * 0.8 7.9 7.9
White 10.3b 9.0 3.5 2.8 10.9b 9.5 15.7 14.9 10.3b 8.9 6.1 5.9 10.9b 9.4
Two or More Races 10.0 10.7 2.9 3.7 11.4 11.9 14.7 12.6 10.5 11.7 3.9 5.9 11.8 12.1
Hispanic or Latino 9.1 9.6 3.1 3.6 10.0 10.5 15.0 12.9 8.9 9.9 5.1 5.3 10.1 10.7
EDUCATION LEVEL                            
< High School da da da da 8.1 9.0 12.2 9.7 7.4 8.9 da da 7.9 9.2
High School Graduate da da da da 9.6 8.8 13.7 11.9 8.8 8.1 da da 9.7 8.8
Some College/Associate’s Degree da da da da 11.4 10.4 14.7 14.1 10.7 9.6 da da 11.4 10.3
College Graduate da da da da 10.6a 9.3 16.5 15.5 10.2a 8.8 da da 10.6a 9.3
EMPLOYMENT STATUS                            
Full‑Time da da da da 12.5a 11.2 18.0a 15.2 11.7a 10.7 da da 12.4a 11.2
Part‑Time da da da da 10.8 9.3 12.5 12.3 10.2 8.2 da da 11.1 9.4
Unemployed da da da da 14.7 14.4 14.5 12.5 14.7 15.2 da da 15.6 15.0
Other1 da da da da 6.9 6.7 10.4 11.0 6.6 6.3 da da 6.9 6.6

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Alcohol use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.10A – Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
TOTAL 48,351b 44,576 2,024 1,877 46,327b 42,699 9,056 8,577 37,271a 34,121
SEX                    
Male 28,114a 25,510 859 918 27,255b 24,592 4,800 4,503 22,455a 20,089
Female 20,237 19,065 1,164a 959 19,073 18,107 4,257 4,075 14,816 14,032
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 39,909b 35,767 1,471 1,270 38,438b 34,497 6,902 6,409 31,536b 28,088
AIAN 290 357 13 20 278 337 51 47 227 289
Asian 1,621 1,376 59 33 1,563 1,342 318 253 1,245 1,089
Black or African American 6,081 5,636 270 291 5,811 5,345 1,204 1,135 4,607 4,209
NHPI 149 177 1 * 148 176 * * 114 *
White 30,302b 26,246 1,021a 807 29,282b 25,439 4,926 4,492 24,355b 20,947
Two or More Races 1,465a 1,975 108 116 1,358a 1,859 369 451 989a 1,408
Hispanic or Latino 8,442 8,809 553 607 7,889 8,202 2,154 2,169 5,735 6,033
EDUCATION LEVEL                    
< High School da da da da 4,106 4,335 890 809 3,216 3,526
High School Graduate da da da da 13,171 12,316 3,087 3,133 10,084 9,183
Some College/Associate’s Degree da da da da 15,551b 13,676 3,565 3,216 11,986a 10,460
College Graduate da da da da 13,500 12,371 1,514 1,419 11,986 10,952
EMPLOYMENT STATUS                    
Full‑Time da da da da 22,752a 20,911 4,163 3,726 18,589 17,184
Part‑Time da da da da 6,260 6,056 2,118 2,127 4,142 3,929
Unemployed da da da da 3,622 3,677 1,080 1,040 2,542 2,636
Other1 da da da da 13,693a 12,055 1,695 1,683 11,998a 10,371

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.10B – Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
TOTAL 16.8b 15.3 7.8 7.4 17.7b 16.1 25.9a 23.8 16.4b 14.9
SEX                    
Male 19.9b 18.1 6.5 7.1 21.3b 19.3 27.3a 24.7 20.4b 18.4
Female 13.7a 12.7 9.2a 7.7 14.2a 13.2 24.5 22.8 12.6 11.7
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 17.1b 15.3 7.7 6.8 17.9b 16.0 26.4a 24.1 16.7b 14.9
AIAN 21.3 19.3 6.2 7.5 24.0 21.3 32.8 23.0 22.7 21.1
Asian 8.7 7.2 3.9 2.2 9.1 7.6 13.2 10.0 8.5 7.2
Black or African American 17.2 16.3 7.6 8.5 18.3 17.2 26.2 24.4 17.0 15.9
NHPI 12.1 16.6 1.7 * 12.8 17.6 * * 11.3 *
White 17.8b 15.6 8.1 6.7 18.5b 16.3 27.8 25.8 17.4b 15.1
Two or More Races 22.6 20.9 10.3 8.7 24.9 22.9 32.2 26.5 23.0 21.9
Hispanic or Latino 15.5 15.6 8.0 8.9 16.5 16.5 24.6 22.8 14.7 15.0
EDUCATION LEVEL                    
< High School da da da da 17.1 17.8 25.2 21.8 15.7 17.0
High School Graduate da da da da 18.7 17.4 25.4 24.4 17.3 15.8
Some College/Associate’s Degree da da da da 20.0b 17.7 26.9a 24.1 18.5a 16.4
College Graduate da da da da 15.0a 13.4 25.3 22.9 14.3a 12.7
EMPLOYMENT STATUS                    
Full‑Time da da da da 18.8 17.7 29.7 27.2 17.3 16.5
Part‑Time da da da da 19.3 17.4 24.1 22.1 17.6 15.6
Unemployed da da da da 28.1 26.8 29.4 25.5 27.6 27.4
Other1 da da da da 14.3b 12.2 20.1 19.4 13.7b 11.5

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.11A – Drug Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
TOTAL 28,184a 25,969 1,705 1,511 26,480a 24,458 6,210 5,723 20,269 18,735
GEOGRAPHIC DIVISION                    
Northeast 4,967 4,418 216 182 4,751 4,236 1,084 928 3,666 3,308
New England 1,432 1,335 87a 40 1,345 1,295 324 305 1,021 990
Middle Atlantic 3,535 3,083 130 142 3,406 2,941 760 622 2,645 2,319
Midwest 6,096 5,906 302 349 5,794 5,557 1,398 1,405 4,396 4,153
East North Central 4,274 4,079 205 240 4,069 3,838 980 1,003 3,089 2,835
West North Central 1,822 1,827 98 108 1,725 1,719 417 401 1,307 1,318
South 10,168 9,077 705 629 9,463 8,448 2,100 1,949 7,363 6,499
South Atlantic 5,560 4,825 306 336 5,254 4,489 1,134 1,070 4,120 3,419
East South Central 1,546 1,368 119 74 1,427 1,293 253 244 1,174 1,049
West South Central 3,062 2,884 280 220 2,783 2,665 713 634 2,070 2,030
West 6,953 6,568 481 351 6,472 6,217 1,628 1,442 4,844 4,775
Mountain 2,593 2,195 201 150 2,393 2,045 527 439 1,866 1,607
Pacific 4,360 4,373 281 201 4,079 4,171 1,101 1,003 2,978 3,168
COUNTY TYPE                    
Large Metro 15,816 14,660 896 829 14,920 13,831 3,425 3,242 11,494 10,590
Small Metro 8,749 8,431 632 541 8,117 7,889 2,099 1,900 6,018 5,990
Nonmetro 3,619a 2,878 176 141 3,443a 2,737 686 582 2,757 2,155
Urbanized 1,408 1,223 61 65 1,347 1,158 355 294 991 864
Less Urbanized 1,403 1,161 62 53 1,341 1,108 222 204 1,119 904
Completely Rural 809a 493 54 22 755 471 109 84 646 387
POVERTY LEVEL1                    
Less Than 100% 6,687 6,850 375 417 6,312 6,432 1,432 1,629 4,880 4,804
100‑199% 6,652 6,548 402 409 6,250 6,139 1,492 1,560 4,758 4,579
200% or More 14,833b 12,531 928b 685 13,905b 11,846 3,274b 2,495 10,631a 9,352
HEALTH INSURANCE2                    
Private 13,644a 12,028 842 671 12,801a 11,357 3,239 3,096 9,562a 8,262
Medicaid/CHIP 9,404 9,171 799 853 8,605 8,318 1,716 1,620 6,889 6,698
Other3 4,995 4,477 58 74 4,937 4,403 476 369 4,461 4,034
No Coverage 3,664 3,162 99 51 3,565 3,111 1,016 828 2,549 2,284

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Drug use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on drug use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.11B – Drug Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
TOTAL 9.8b 8.9 6.6 5.9 10.1a 9.2 17.8b 15.9 8.9a 8.2
GEOGRAPHIC DIVISION                    
Northeast 10.0 8.8 5.3 4.6 10.4 9.2 18.4a 15.3 9.2 8.3
New England 10.7 9.9 8.3a 3.9 10.9 10.4 19.7 18.4 9.6 9.2
Middle Atlantic 9.7 8.4 4.3 4.8 10.2 8.7 17.8a 14.1 9.1 7.9
Midwest 10.3 10.0 5.6 6.6 10.8 10.3 19.2 18.8 9.5 8.9
East North Central 10.6 10.0 5.6 6.7 11.0 10.3 19.8 19.8 9.7 8.8
West North Central 9.9 9.8 5.5 6.2 10.3 10.2 17.9 16.7 9.1 9.1
South 9.1a 8.0 6.8 6.2 9.4a 8.2 15.5 13.9 8.4 7.3
South Atlantic 9.4a 8.1 6.0 6.7 9.7a 8.2 16.6 15.1 8.7a 7.2
East South Central 9.2 8.1 7.7 4.9 9.4 8.4 12.4 11.4 8.9 7.9
West South Central 8.6 8.0 7.7 6.1 8.7 8.2 15.3 13.1 7.6 7.3
West 10.2 9.6 7.8 5.8 10.4 10.0 19.8 17.0 9.0 8.9
Mountain 11.7 9.8 9.7 7.3 11.9 10.1 18.7 15.0 10.8 9.2
Pacific 9.5 9.5 6.9 5.1 9.8 9.9 20.3 18.0 8.2 8.7
COUNTY TYPE                    
Large Metro 9.5 8.8 6.0 5.7 9.9 9.1 17.9a 15.8 8.7 8.1
Small Metro 9.9 9.3 7.8 6.6 10.1 9.5 18.1 16.3 8.7 8.4
Nonmetro 10.8a 8.6 6.3 5.1 11.2a 8.9 16.3 15.1 10.4a 8.0
Urbanized 10.5 10.1 5.8 6.7 10.9 10.4 17.6 20.0 9.6 8.9
Less Urbanized 11.8a 8.5 6.0 4.6 12.4a 8.9 16.3 13.0 11.8a 8.3
Completely Rural 9.8a 6.3 7.4 3.7 10.0a 6.6 13.0 10.3 9.7a 6.1
POVERTY LEVEL1                    
Less Than 100% 14.4 14.0 6.8 7.4 15.4 14.9 17.1 16.6 15.0 14.4
100‑199% 12.0 10.7 7.5 7.2 12.4 11.1 17.6 18.4 11.4 9.8
200% or More 8.0b 6.9 6.1a 4.9 8.1b 7.1 18.3b 14.3 7.0 6.3
HEALTH INSURANCE2                    
Private 7.8a 7.0 5.8 4.8 7.9a 7.2 16.4 15.0 6.8 6.0
Medicaid/CHIP 15.9 15.0 7.6 8.1 17.7 16.4 19.1 17.4 17.4 16.2
Other3 6.3 5.4 4.2 5.1 6.3 5.4 17.0 13.7 5.9 5.1
No Coverage 14.5 12.7 8.2 4.5 14.9 13.1 20.2 16.7 13.4 12.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Drug use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on drug use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.12A – Alcohol Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)		 Aged 12‑20
(2024)		 Aged 12‑20
(2025)		 Aged 21+
(2024)		 Aged 21+
(2025)
TOTAL 27,913a 25,746 775 710 27,138a 25,036 5,029 4,731 22,108a 20,304 1,998 2,039 25,915a 23,707
GEOGRAPHIC DIVISION                            
Northeast 4,732 4,343 127 84 4,605 4,259 758 791 3,847 3,468 285 239 4,448 4,104
New England 1,331 1,394 41 30 1,290 1,364 233 308 1,058 1,056 91 97 1,240 1,297
Middle Atlantic 3,401 2,949 87 54 3,315 2,895 525 483 2,789 2,412 194 142 3,208 2,807
Midwest 6,241 5,677 150 125 6,090 5,552 1,097 1,039 4,993 4,513 429 426 5,812 5,251
East North Central 4,433 4,126 90 87 4,344 4,039 714 758 3,629 3,281 280 289 4,153 3,837
West North Central 1,808 1,551 61 38 1,747 1,513 383 281 1,364 1,232 148 137 1,659 1,414
South 9,971 9,413 303 314 9,668 9,099 1,974 1,800 7,694 7,299 803 857 9,169 8,556
South Atlantic 5,387 4,868 141 171 5,245 4,697 1,009 940 4,236 3,756 391 473 4,996 4,394
East South Central 1,455 1,355 43 40 1,412 1,315 302 231 1,110 1,084 161 105 1,294 1,250
West South Central 3,129 3,190 119 103 3,011 3,087 662 629 2,348 2,459 251 278 2,878 2,912
West 6,968 6,313 195 187 6,774 6,126 1,200 1,101 5,573 5,025 482 517 6,486 5,796
Mountain 2,325 2,138 80 63 2,245 2,075 449 423 1,796 1,653 178 184 2,146 1,954
Pacific 4,644 4,175 115 125 4,529 4,050 752 678 3,777 3,372 304 334 4,340 3,842
COUNTY TYPE                            
Large Metro 16,866a 14,988 436 412 16,430a 14,576 2,726 2,815 13,704b 11,761 1,001 1,128 15,865b 13,860
Small Metro 8,300 8,307 243 227 8,057 8,080 1,702 1,430 6,355 6,649 692 685 7,607 7,622
Nonmetro 2,747 2,452 96 71 2,651 2,381 601 486 2,050 1,894 304 226 2,443 2,225
Urbanized 1,100 907 23 19 1,078 887 306 194 772 693 122 89 979 818
Less Urbanized 1,051 1,072 41 35 1,010 1,036 213 210 797 826 120 96 931 975
Completely Rural 596 473 33 16 563 457 82 82 481 375 62 41 534 432
POVERTY LEVEL1                            
Less Than 100% 4,499 4,254 133 157 4,367 4,096 1,150 1,319 3,217 2,777 503 641 3,997 3,612
100‑199% 4,597 5,039 156 164 4,441 4,875 1,207 1,124 3,234 3,751 430 437 4,167 4,602
200% or More 18,790b 16,397 486 388 18,303b 16,008 2,646a 2,232 15,657b 13,776 1,047 909 17,743b 15,488
HEALTH INSURANCE2                            
Private 17,371b 15,431 456 389 16,915b 15,043 2,980 2,897 13,935b 12,145 1,129 1,155 16,242b 14,277
Medicaid/CHIP 5,415 5,650 310 335 5,105 5,315 1,062 1,086 4,043 4,229 610 719 4,805 4,931
Other3 4,748 4,737 29 54 4,719 4,683 366 335 4,353 4,348 124 143 4,624 4,593
No Coverage 3,229 3,001 34a 11 3,194 2,990 773a 578 2,421 2,412 230 153 2,999 2,848

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Alcohol use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.12B – Alcohol Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)		 Aged 12‑20
(2024)		 Aged 12‑20
(2025)		 Aged 21+
(2024)		 Aged 21+
(2025)
TOTAL 9.7b 8.9 3.0 2.8 10.3b 9.4 14.4a 13.1 9.7a 8.9 5.2 5.2 10.4b 9.4
GEOGRAPHIC DIVISION                            
Northeast 9.5 8.7 3.1 2.1 10.1 9.2 12.8 13.0 9.7 8.7 4.7 3.8 10.2 9.4
New England 10.0 10.4 3.9 2.9 10.5 11.0 14.2 18.6 9.9 9.8 5.6 6.1 10.6 10.9
Middle Atlantic 9.4 8.0 2.8 1.8 9.9 8.6 12.3 10.9 9.6 8.2 4.3 3.1 10.1 8.8
Midwest 10.6 9.6 2.8 2.4 11.4 10.3 15.1 13.9 10.8 9.7 5.3 5.2 11.4 10.3
East North Central 11.0 10.1 2.5 2.4 11.8 10.9 14.4 15.0 11.4 10.2 5.1 5.3 11.9 10.9
West North Central 9.8 8.4 3.5 2.2 10.5 9.0 16.4a 11.7 9.5 8.5 5.6 5.0 10.5 8.9
South 8.9 8.3 2.9 3.1 9.6 8.9 14.6 12.8 8.8 8.2 5.3 5.6 9.5 8.8
South Atlantic 9.1 8.1 2.8 3.4 9.7 8.6 14.8 13.3 9.0 7.9 5.2 6.1 9.7 8.4
East South Central 8.7 8.0 2.7 2.7 9.3 8.5 14.8 10.8 8.4 8.2 7.0 4.6 9.0 8.6
West South Central 8.8 8.8 3.3 2.9 9.4 9.5 14.3 13.0 8.6 8.9 4.7 5.2 9.5 9.5
West 10.2 9.2 3.2 3.1 10.9 9.8 14.6 13.0 10.4 9.3 5.3 5.5 11.0 9.8
Mountain 10.5 9.6 3.9 3.0 11.2 10.2 16.0 14.5 10.4 9.5 5.8 5.8 11.2 10.2
Pacific 10.1 9.1 2.8 3.2 10.8 9.6 13.8 12.2 10.4 9.2 5.0 5.4 10.9 9.6
COUNTY TYPE                            
Large Metro 10.2b 9.0 2.9 2.8 10.9b 9.6 14.2 13.7 10.4b 9.0 4.6 5.1 11.0b 9.6
Small Metro 9.4 9.1 3.0 2.8 10.0 9.8 14.7a 12.3 9.2 9.3 5.6 5.4 9.9 9.7
Nonmetro 8.2 7.3 3.4 2.6 8.6 7.7 14.3 12.6 7.7 7.0 6.7 5.3 8.4 7.6
Urbanized 8.2 7.5 2.2 2.0 8.8 7.9 15.1 13.2 7.5 7.1 6.5 5.7 8.5 7.7
Less Urbanized 8.8 7.8 4.0 3.0 9.3 8.3 15.7 13.4 8.4 7.6 7.6 5.4 9.0 8.2
Completely Rural 7.2 6.1 4.5 2.7 7.5 6.4 9.8 10.0 7.2 5.9 5.9 4.2 7.4 6.3
POVERTY LEVEL1                            
Less Than 100% 9.7 8.7 2.4 2.8 10.7 9.5 13.7 13.4 9.9 8.3 5.6 6.4 10.6 9.3
100‑199% 8.3 8.3 2.9 2.9 8.8 8.8 14.2 13.3 7.7 8.0 5.2 4.9 8.8 8.8
200% or More 10.1b 9.1 3.2 2.8 10.7b 9.6 14.8a 12.8 10.2a 9.3 4.9 4.5 10.8b 9.7
HEALTH INSURANCE2                            
Private 9.9a 9.0 3.1 2.8 10.5a 9.6 15.1 14.0 9.9a 8.9 5.3 5.5 10.5a 9.5
Medicaid/CHIP 9.2 9.2 3.0 3.2 10.5 10.5 11.8 11.7 10.2 10.2 4.2 4.8 10.8 10.7
Other3 6.0 5.7 2.1 3.7 6.1 5.7 13.1 12.5 5.8 5.5 5.2 5.6 6.0 5.7
No Coverage 12.8 12.0 2.8a 1.0 13.3 12.5 15.3a 11.7 12.8 12.8 7.9 5.4 13.4 12.9

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Alcohol use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.13A – Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
TOTAL 48,351b 44,576 2,024 1,877 46,327b 42,699 9,056 8,577 37,271a 34,121
GEOGRAPHIC DIVISION                    
Northeast 8,428 7,585 278 240 8,149 7,345 1,509 1,368 6,641 5,977
New England 2,456 2,361 102 63 2,354 2,298 468 499 1,886 1,799
Middle Atlantic 5,972 5,224 177 177 5,795 5,048 1,041 870 4,755 4,178
Midwest 10,475 10,212 360 432 10,115 9,780 2,012 1,988 8,103 7,792
East North Central 7,391 7,213 246 299 7,145 6,914 1,359 1,430 5,785 5,485
West North Central 3,085 3,000 114 134 2,970 2,866 653 558 2,317 2,307
South 17,371 15,864 812 777 16,559 15,087 3,254 3,142 13,306 11,945
South Atlantic 9,459 8,322 361 411 9,098 7,911 1,673 1,675 7,425a 6,235
East South Central 2,571 2,436 132 98 2,438 2,338 455 432 1,983 1,906
West South Central 5,342 5,106 319 267 5,023 4,839 1,126 1,035 3,897 3,804
West 12,077 10,914 573a 428 11,504 10,486 2,282 2,079 9,222 8,407
Mountain 4,163 3,788 233 176 3,930 3,611 788 709 3,142 2,902
Pacific 7,914 7,127 341 252 7,574 6,875 1,494 1,370 6,080 5,505
COUNTY TYPE                    
Large Metro 28,146a 25,384 1,108 1,052 27,038a 24,332 4,923 4,930 22,115b 19,402
Small Metro 14,688 14,489 704 640 13,984 13,848 3,101 2,773 10,883 11,075
Nonmetro 5,517 4,703 212 184 5,305 4,519 1,032 875 4,274 3,644
Urbanized 2,153 1,806 72 71 2,081 1,735 522 405 1,559 1,330
Less Urbanized 2,093 2,013 75 79 2,018 1,934 344 337 1,674 1,597
Completely Rural 1,270 884 64 34 1,206 849 166 133 1,041 717
POVERTY LEVEL1                    
Less Than 100% 9,468 9,378 430 479 9,038 8,899 2,073 2,377 6,965 6,522
100‑199% 9,528 9,794 467 466 9,061 9,329 2,184 2,209 6,877 7,119
200% or More 29,320b 25,322 1,127 932 28,193b 24,390 4,764b 3,911 23,429b 20,480
HEALTH INSURANCE2                    
Private 27,199b 24,051 1,059 901 26,139b 23,150 5,061 4,947 21,078b 18,203
Medicaid/CHIP 12,545 12,341 899 977 11,646 11,364 2,246 2,135 9,400 9,229
Other3 8,850 8,167 78 111 8,773 8,056 681 612 8,092 7,445
No Coverage 5,596 5,157 123a 59 5,473 5,098 1,387 1,162 4,086 3,936

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.13B – Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
TOTAL 16.8b 15.3 7.8 7.4 17.7b 16.1 25.9a 23.8 16.4b 14.9
GEOGRAPHIC DIVISION                    
Northeast 16.9 15.1 6.8 6.0 17.8 15.9 25.5 22.5 16.7 14.9
New England 18.4 17.6 9.8 6.2 19.1 18.5 28.5 30.1 17.6 16.7
Middle Atlantic 16.4 14.2 5.8 5.9 17.4 15.0 24.4a 19.7 16.4 14.3
Midwest 17.8 17.2 6.7 8.1 18.9 18.1 27.6 26.6 17.5 16.8
East North Central 18.3 17.7 6.7 8.4 19.4 18.6 27.4 28.2 18.2 17.1
West North Central 16.7 16.2 6.5 7.7 17.8 17.0 28.0a 23.2 16.2 16.0
South 15.6a 14.1 7.9 7.7 16.4a 14.7 24.1 22.4 15.2a 13.5
South Atlantic 16.0a 13.9 7.0 8.1 16.8b 14.5 24.6 23.7 15.7b 13.1
East South Central 15.4 14.4 8.5 6.5 16.1 15.2 22.2 20.2 15.1 14.4
West South Central 15.0 14.1 8.7 7.5 15.7 14.9 24.2 21.4 14.3 13.7
West 17.7a 16.0 9.3a 7.1 18.6a 16.8 27.7 24.5 17.2 15.6
Mountain 18.8 16.9 11.3 8.6 19.5 17.8 28.0 24.3 18.1 16.7
Pacific 17.2 15.5 8.4 6.4 18.1 16.3 27.5 24.6 16.7 15.1
COUNTY TYPE                    
Large Metro 17.0b 15.3 7.4 7.3 17.9b 16.1 25.7 24.0 16.8b 14.8
Small Metro 16.6 15.9 8.7 7.8 17.3 16.7 26.8a 23.8 15.8 15.6
Nonmetro 16.5a 14.0 7.6 6.7 17.3a 14.6 24.5 22.6 16.1a 13.5
Urbanized 16.1 14.9 7.0 7.2 16.9 15.5 25.8 27.5 15.2 13.7
Less Urbanized 17.6 14.7 7.3 6.8 18.6 15.5 25.3 21.4 17.6 14.6
Completely Rural 15.4a 11.4 8.9 5.7 16.1a 11.8 19.8 16.2 15.6 11.3
POVERTY LEVEL1                    
Less Than 100% 20.4 19.2 7.8 8.5 22.1 20.6 24.8 24.2 21.4 19.6
100‑199% 17.1 16.1 8.8 8.1 18.0 16.9 25.7 26.1 16.4 15.2
200% or More 15.8b 14.0 7.5 6.6 16.5b 14.7 26.6b 22.4 15.3b 13.8
HEALTH INSURANCE2                    
Private 15.5b 14.1 7.2 6.5 16.2b 14.7 25.7 24.0 14.9b 13.3
Medicaid/CHIP 21.3 20.2 8.6 9.3 24.0 22.5 25.0 22.9 23.8 22.3
Other3 11.2a 9.8 5.6 7.6 11.3a 9.8 24.4 22.8 10.8a 9.4
No Coverage 22.2 20.7 10.2a 5.2 22.8 21.4 27.5a 23.5 21.6 20.8

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

3 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.14A – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2024 and 2025
Age Category Treatment for Drugs1
(2024)		 Treatment for Drugs1
(2025)		 Treatment for Alcohol1
(2024)		 Treatment for Alcohol1
(2025)		 Treatment for Both Drugs and Alcohol1
(2024)		 Treatment for Both Drugs and Alcohol1
(2025)		 Treatment for Substance Use2
(2024)		 Treatment for Substance Use2
(2025)
TOTAL ‑‑ 5,127 ‑‑ 3,766 ‑‑ 1,526 ‑‑ 7,554
12‑20 ‑‑ 581 ‑‑ 280 ‑‑ 137 ‑‑ 759
21 or Older ‑‑ 4,546 ‑‑ 3,487 ‑‑ 1,388 ‑‑ 6,795
12‑17 ‑‑ 383 ‑‑ 165 ‑‑ 104 ‑‑ 470
12‑13 ‑‑ 50 ‑‑ 13 ‑‑ 3 ‑‑ 61
14‑15 ‑‑ 160 ‑‑ 58 ‑‑ 41 ‑‑ 181
16‑17 ‑‑ 173 ‑‑ 94 ‑‑ 60 ‑‑ 229
18 or Older ‑‑ 4,744 ‑‑ 3,601 ‑‑ 1,422 ‑‑ 7,083
18‑25 ‑‑ 566 ‑‑ 433 ‑‑ 174 ‑‑ 845
18‑20 ‑‑ 198 ‑‑ 115 ‑‑ 34 ‑‑ 288
21‑25 ‑‑ 368 ‑‑ 319 ‑‑ 140 ‑‑ 557
26 or Older ‑‑ 4,177 ‑‑ 3,168 ‑‑ 1,248 ‑‑ 6,238
26‑49 ‑‑ 2,686 ‑‑ 1,941 ‑‑ 822 ‑‑ 3,939
26‑29 ‑‑ 343 ‑‑ 312 ‑‑ 173 ‑‑ 513
30‑34 ‑‑ 533 ‑‑ 323 ‑‑ 131 ‑‑ 745
35‑39 ‑‑ 792 ‑‑ 602 ‑‑ 243 ‑‑ 1,164
40‑44 ‑‑ 546 ‑‑ 402 ‑‑ 112 ‑‑ 853
45‑49 ‑‑ 472 ‑‑ 302 ‑‑ 163 ‑‑ 664
50 or Older ‑‑ 1,491 ‑‑ 1,227 ‑‑ 426 ‑‑ 2,299
50‑54 ‑‑ 397 ‑‑ 193 ‑‑ 39 ‑‑ 555
55‑59 ‑‑ 398 ‑‑ 425 ‑‑ 210 ‑‑ 614
60‑64 ‑‑ 321 ‑‑ 220 ‑‑ 103 ‑‑ 438
65 or Older ‑‑ 376 ‑‑ 390 ‑‑ 74 ‑‑ 693

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown information for the specific substance(s) for which they received substance use treatment were excluded from the respective analyses.

2 Includes data from respondents who were classified as having received substance use treatment but had unknown information regarding whether they received treatment specifically for drugs or alcohol.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.14B – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2024 and 2025
Age Category Treatment for Drugs1
(2024)		 Treatment for Drugs1
(2025)		 Treatment for Alcohol1
(2024)		 Treatment for Alcohol1
(2025)		 Treatment for Both Drugs and Alcohol1
(2024)		 Treatment for Both Drugs and Alcohol1
(2025)		 Treatment for Substance Use2
(2024)		 Treatment for Substance Use2
(2025)
TOTAL ‑‑ 1.8 ‑‑ 1.3 ‑‑ 0.5 ‑‑ 2.6
12‑20 ‑‑ 1.5 ‑‑ 0.7 ‑‑ 0.3 ‑‑ 1.9
21 or Older ‑‑ 1.8 ‑‑ 1.4 ‑‑ 0.6 ‑‑ 2.7
12‑17 ‑‑ 1.5 ‑‑ 0.6 ‑‑ 0.4 ‑‑ 1.8
12‑13 ‑‑ 0.6 ‑‑ 0.2 ‑‑ <0.1 ‑‑ 0.8
14‑15 ‑‑ 1.8 ‑‑ 0.7 ‑‑ 0.5 ‑‑ 2.1
16‑17 ‑‑ 1.9 ‑‑ 1.1 ‑‑ 0.7 ‑‑ 2.6
18 or Older ‑‑ 1.8 ‑‑ 1.4 ‑‑ 0.5 ‑‑ 2.7
18‑25 ‑‑ 1.6 ‑‑ 1.2 ‑‑ 0.5 ‑‑ 2.3
18‑20 ‑‑ 1.4 ‑‑ 0.8 ‑‑ 0.2 ‑‑ 2.1
21‑25 ‑‑ 1.7 ‑‑ 1.4 ‑‑ 0.6 ‑‑ 2.5
26 or Older ‑‑ 1.8 ‑‑ 1.4 ‑‑ 0.5 ‑‑ 2.7
26‑49 ‑‑ 2.6 ‑‑ 1.8 ‑‑ 0.8 ‑‑ 3.7
26‑29 ‑‑ 2.0 ‑‑ 1.8 ‑‑ 1.0 ‑‑ 3.0
30‑34 ‑‑ 2.3 ‑‑ 1.4 ‑‑ 0.6 ‑‑ 3.2
35‑39 ‑‑ 3.5 ‑‑ 2.7 ‑‑ 1.1 ‑‑ 5.2
40‑44 ‑‑ 2.5 ‑‑ 1.8 ‑‑ 0.5 ‑‑ 3.9
45‑49 ‑‑ 2.3 ‑‑ 1.5 ‑‑ 0.8 ‑‑ 3.3
50 or Older ‑‑ 1.2 ‑‑ 1.0 ‑‑ 0.3 ‑‑ 1.9
50‑54 ‑‑ 2.2 ‑‑ 1.1 ‑‑ 0.2 ‑‑ 3.1
55‑59 ‑‑ 2.0 ‑‑ 2.2 ‑‑ 1.1 ‑‑ 3.1
60‑64 ‑‑ 1.4 ‑‑ 1.0 ‑‑ 0.5 ‑‑ 1.9
65 or Older ‑‑ 0.6 ‑‑ 0.6 ‑‑ 0.1 ‑‑ 1.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown information for the specific substance(s) for which they received substance use treatment were excluded from the respective analyses.

2 Includes data from respondents who were classified as having received substance use treatment but had unknown information regarding whether they received treatment specifically for drugs or alcohol.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.15A – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
TOTAL ‑‑ 7,554 ‑‑ 470 ‑‑ 7,083 ‑‑ 845 ‑‑ 6,238
SEX                    
Male ‑‑ 4,111 ‑‑ 253 ‑‑ 3,859 ‑‑ 438 ‑‑ 3,421
Female ‑‑ 3,442 ‑‑ 218 ‑‑ 3,225 ‑‑ 408 ‑‑ 2,817
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino ‑‑ 6,268 ‑‑ 331 ‑‑ 5,937 ‑‑ 639 ‑‑ 5,298
AIAN ‑‑ 98 ‑‑ 7 ‑‑ 91 ‑‑ 21 ‑‑ 70
Asian ‑‑ 131 ‑‑ * ‑‑ 117 ‑‑ 18 ‑‑ 100
Black or African American ‑‑ 839 ‑‑ 74 ‑‑ 766 ‑‑ 95 ‑‑ 671
NHPI ‑‑ 14 ‑‑ * ‑‑ 12 ‑‑ * ‑‑ 10
White ‑‑ 4,792 ‑‑ 214 ‑‑ 4,578 ‑‑ 479 ‑‑ 4,099
Two or More Races ‑‑ 393 ‑‑ 21 ‑‑ 373 ‑‑ 23 ‑‑ 349
Hispanic or Latino ‑‑ 1,286 ‑‑ 139 ‑‑ 1,147 ‑‑ 207 ‑‑ 940
EDUCATION LEVEL                    
< High School da da da da ‑‑ 1,047 ‑‑ 128 ‑‑ 919
High School Graduate da da da da ‑‑ 2,072 ‑‑ 315 ‑‑ 1,757
Some College/Associate’s Degree da da da da ‑‑ 2,737 ‑‑ 296 ‑‑ 2,441
College Graduate da da da da ‑‑ 1,227 ‑‑ 106 ‑‑ 1,121
EMPLOYMENT STATUS                    
Full‑Time da da da da ‑‑ 2,526 ‑‑ 259 ‑‑ 2,267
Part‑Time da da da da ‑‑ 1,110 ‑‑ 275 ‑‑ 835
Unemployed da da da da ‑‑ 780 ‑‑ 140 ‑‑ 640
Other1 da da da da ‑‑ 2,667 ‑‑ 171 ‑‑ 2,496

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.15B – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
TOTAL ‑‑ 2.6 ‑‑ 1.8 ‑‑ 2.7 ‑‑ 2.3 ‑‑ 2.7
SEX                    
Male ‑‑ 2.9 ‑‑ 1.9 ‑‑ 3.0 ‑‑ 2.4 ‑‑ 3.1
Female ‑‑ 2.3 ‑‑ 1.7 ‑‑ 2.3 ‑‑ 2.3 ‑‑ 2.4
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino ‑‑ 2.7 ‑‑ 1.8 ‑‑ 2.8 ‑‑ 2.4 ‑‑ 2.8
AIAN ‑‑ 5.3 ‑‑ 2.7 ‑‑ 5.7 ‑‑ 10.1 ‑‑ 5.1
Asian ‑‑ 0.7 ‑‑ * ‑‑ 0.7 ‑‑ 0.7 ‑‑ 0.7
Black or African American ‑‑ 2.4 ‑‑ 2.2 ‑‑ 2.5 ‑‑ 2.0 ‑‑ 2.5
NHPI ‑‑ 1.3 ‑‑ * ‑‑ 1.2 ‑‑ * ‑‑ 1.1
White ‑‑ 2.9 ‑‑ 1.8 ‑‑ 2.9 ‑‑ 2.8 ‑‑ 3.0
Two or More Races ‑‑ 4.2 ‑‑ 1.6 ‑‑ 4.6 ‑‑ 1.4 ‑‑ 5.4
Hispanic or Latino ‑‑ 2.3 ‑‑ 2.0 ‑‑ 2.3 ‑‑ 2.2 ‑‑ 2.3
EDUCATION LEVEL                    
< High School da da da da ‑‑ 4.3 ‑‑ 3.4 ‑‑ 4.4
High School Graduate da da da da ‑‑ 2.9 ‑‑ 2.5 ‑‑ 3.0
Some College/Associate’s Degree da da da da ‑‑ 3.5 ‑‑ 2.2 ‑‑ 3.8
College Graduate da da da da ‑‑ 1.3 ‑‑ 1.7 ‑‑ 1.3
EMPLOYMENT STATUS                    
Full‑Time da da da da ‑‑ 2.1 ‑‑ 1.9 ‑‑ 2.2
Part‑Time da da da da ‑‑ 3.2 ‑‑ 2.9 ‑‑ 3.3
Unemployed da da da da ‑‑ 5.7 ‑‑ 3.4 ‑‑ 6.7
Other1 da da da da ‑‑ 2.7 ‑‑ 2.0 ‑‑ 2.8

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.16A – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Treatment for Drugs1
(2024)		 Treatment for Drugs1
(2025)		 Treatment for Alcohol1
(2024)		 Treatment for Alcohol1
(2025)		 Treatment for Both Drugs and Alcohol1
(2024)		 Treatment for Both Drugs and Alcohol1
(2025)		 Treatment for Substance Use2
(2024)		 Treatment for Substance Use2
(2025)
TOTAL ‑‑ 5,127 ‑‑ 3,766 ‑‑ 1,526 ‑‑ 7,554
SEX                
Male ‑‑ 2,674 ‑‑ 2,273 ‑‑ 929 ‑‑ 4,111
Female ‑‑ 2,453 ‑‑ 1,493 ‑‑ 596 ‑‑ 3,442
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino ‑‑ 4,298 ‑‑ 2,998 ‑‑ 1,197 ‑‑ 6,268
AIAN ‑‑ 68 ‑‑ 63 ‑‑ 36 ‑‑ 98
Asian ‑‑ 92 ‑‑ 22 ‑‑ 10 ‑‑ 131
Black or African American ‑‑ 465 ‑‑ 532 ‑‑ 179 ‑‑ 839
NHPI ‑‑ 10 ‑‑ 6 ‑‑ 2 ‑‑ 14
White ‑‑ 3,370 ‑‑ 2,190 ‑‑ 883 ‑‑ 4,792
Two or More Races ‑‑ 294 ‑‑ 185 ‑‑ 88 ‑‑ 393
Hispanic or Latino ‑‑ 829 ‑‑ 768 ‑‑ 328 ‑‑ 1,286

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown information for the specific substance(s) for which they received substance use treatment were excluded from the respective analyses.

2 Includes data from respondents who were classified as having received substance use treatment but had unknown information regarding whether they received treatment specifically for drugs or alcohol.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.16B – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Treatment for Drugs1
(2024)		 Treatment for Drugs1
(2025)		 Treatment for Alcohol1
(2024)		 Treatment for Alcohol1
(2025)		 Treatment for Both Drugs and Alcohol1
(2024)		 Treatment for Both Drugs and Alcohol1
(2025)		 Treatment for Substance Use2
(2024)		 Treatment for Substance Use2
(2025)
TOTAL ‑‑ 1.8 ‑‑ 1.3 ‑‑ 0.5 ‑‑ 2.6
SEX                
Male ‑‑ 1.9 ‑‑ 1.6 ‑‑ 0.7 ‑‑ 2.9
Female ‑‑ 1.6 ‑‑ 1.0 ‑‑ 0.4 ‑‑ 2.3
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino ‑‑ 1.8 ‑‑ 1.3 ‑‑ 0.5 ‑‑ 2.7
AIAN ‑‑ 3.7 ‑‑ 3.4 ‑‑ 2.0 ‑‑ 5.3
Asian ‑‑ 0.5 ‑‑ 0.1 ‑‑ 0.1 ‑‑ 0.7
Black or African American ‑‑ 1.3 ‑‑ 1.5 ‑‑ 0.5 ‑‑ 2.4
NHPI ‑‑ 0.9 ‑‑ 0.6 ‑‑ 0.2 ‑‑ 1.3
White ‑‑ 2.0 ‑‑ 1.3 ‑‑ 0.5 ‑‑ 2.9
Two or More Races ‑‑ 3.1 ‑‑ 2.0 ‑‑ 0.9 ‑‑ 4.2
Hispanic or Latino ‑‑ 1.5 ‑‑ 1.4 ‑‑ 0.6 ‑‑ 2.3

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown information for the specific substance(s) for which they received substance use treatment were excluded from the respective analyses.

2 Includes data from respondents who were classified as having received substance use treatment but had unknown information regarding whether they received treatment specifically for drugs or alcohol.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.17A – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older with Past Year Substance Use Disorder; by Age Group and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
TOTAL ‑‑ 4,898 ‑‑ 286 ‑‑ 4,612 ‑‑ 640 ‑‑ 3,972
SEX                    
Male ‑‑ 2,774 ‑‑ 169 ‑‑ 2,605 ‑‑ 345 ‑‑ 2,259
Female ‑‑ 2,124 ‑‑ 117 ‑‑ 2,007 ‑‑ 295 ‑‑ 1,713
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino ‑‑ 3,947 ‑‑ 180 ‑‑ 3,767 ‑‑ 488 ‑‑ 3,279
AIAN ‑‑ 70 ‑‑ * ‑‑ 63 ‑‑ * ‑‑ *
Asian ‑‑ 105 ‑‑ * ‑‑ 105 ‑‑ * ‑‑ *
Black or African American ‑‑ 530 ‑‑ 40 ‑‑ 490 ‑‑ 69 ‑‑ 421
NHPI ‑‑ * ‑‑ * ‑‑ * ‑‑ * ‑‑ *
White ‑‑ 2,968 ‑‑ 124 ‑‑ 2,843 ‑‑ 372 ‑‑ 2,471
Two or More Races ‑‑ 268 ‑‑ * ‑‑ 260 ‑‑ 18 ‑‑ 242
Hispanic or Latino ‑‑ 951 ‑‑ 106 ‑‑ 845 ‑‑ 152 ‑‑ 693
EDUCATION LEVEL                    
< High School da da da da ‑‑ 814 ‑‑ 87 ‑‑ 726
High School Graduate da da da da ‑‑ 1,324 ‑‑ 247 ‑‑ 1,077
Some College/Associate’s Degree da da da da ‑‑ 1,789 ‑‑ 212 ‑‑ 1,578
College Graduate da da da da ‑‑ 685 ‑‑ 94 ‑‑ 591
EMPLOYMENT STATUS                    
Full‑Time da da da da ‑‑ 1,626 ‑‑ 200 ‑‑ 1,425
Part‑Time da da da da ‑‑ 775 ‑‑ 204 ‑‑ 571
Unemployed da da da da ‑‑ 495 ‑‑ 106 ‑‑ 388
Other1 da da da da ‑‑ 1,716 ‑‑ 129 ‑‑ 1,587

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.17B – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older with Past Year Substance Use Disorder; by Age Group and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
TOTAL ‑‑ 11.0 ‑‑ 15.3 ‑‑ 10.8 ‑‑ 7.5 ‑‑ 11.6
SEX                    
Male ‑‑ 10.9 ‑‑ 18.5 ‑‑ 10.6 ‑‑ 7.7 ‑‑ 11.2
Female ‑‑ 11.1 ‑‑ 12.2 ‑‑ 11.1 ‑‑ 7.2 ‑‑ 12.2
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino ‑‑ 11.0 ‑‑ 14.2 ‑‑ 10.9 ‑‑ 7.6 ‑‑ 11.7
AIAN ‑‑ 19.5 ‑‑ * ‑‑ 18.8 ‑‑ * ‑‑ *
Asian ‑‑ 7.6 ‑‑ * ‑‑ 7.8 ‑‑ * ‑‑ *
Black or African American ‑‑ 9.4 ‑‑ 13.8 ‑‑ 9.2 ‑‑ 6.1 ‑‑ 10.0
NHPI ‑‑ * ‑‑ * ‑‑ * ‑‑ * ‑‑ *
White ‑‑ 11.3 ‑‑ 15.4 ‑‑ 11.2 ‑‑ 8.3 ‑‑ 11.8
Two or More Races ‑‑ 13.6 ‑‑ * ‑‑ 14.0 ‑‑ 4.0 ‑‑ 17.2
Hispanic or Latino ‑‑ 10.8 ‑‑ 17.5 ‑‑ 10.3 ‑‑ 7.0 ‑‑ 11.5
EDUCATION LEVEL                    
< High School da da da da ‑‑ 18.8 ‑‑ 10.8 ‑‑ 20.6
High School Graduate da da da da ‑‑ 10.7 ‑‑ 7.9 ‑‑ 11.7
Some College/Associate’s Degree da da da da ‑‑ 13.1 ‑‑ 6.6 ‑‑ 15.1
College Graduate da da da da ‑‑ 5.5 ‑‑ 6.6 ‑‑ 5.4
EMPLOYMENT STATUS                    
Full‑Time da da da da ‑‑ 7.8 ‑‑ 5.4 ‑‑ 8.3
Part‑Time da da da da ‑‑ 12.8 ‑‑ 9.6 ‑‑ 14.5
Unemployed da da da da ‑‑ 13.5 ‑‑ 10.2 ‑‑ 14.7
Other1 da da da da ‑‑ 14.2 ‑‑ 7.7 ‑‑ 15.3

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.18A – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Treatment for Drugs1
(2024)		 Treatment for Drugs1
(2025)		 Treatment for Alcohol1
(2024)		 Treatment for Alcohol1
(2025)		 Treatment for Both Drugs and Alcohol1
(2024)		 Treatment for Both Drugs and Alcohol1
(2025)		 Treatment for Substance Use2
(2024)		 Treatment for Substance Use2
(2025)
TOTAL ‑‑ 5,127 ‑‑ 3,766 ‑‑ 1,526 ‑‑ 7,554
GEOGRAPHIC DIVISION                
Northeast ‑‑ 1,020 ‑‑ 737 ‑‑ 301 ‑‑ 1,476
New England ‑‑ 230 ‑‑ 158 ‑‑ 61 ‑‑ 332
Middle Atlantic ‑‑ 789 ‑‑ 579 ‑‑ 240 ‑‑ 1,144
Midwest ‑‑ 1,098 ‑‑ 854 ‑‑ 275 ‑‑ 1,731
East North Central ‑‑ 837 ‑‑ 647 ‑‑ 208 ‑‑ 1,314
West North Central ‑‑ 261 ‑‑ 207 ‑‑ 67 ‑‑ 418
South ‑‑ 1,822 ‑‑ 1,212 ‑‑ 571 ‑‑ 2,542
South Atlantic ‑‑ 1,056 ‑‑ 707 ‑‑ 317 ‑‑ 1,461
East South Central ‑‑ 373 ‑‑ 153 ‑‑ 73 ‑‑ 454
West South Central ‑‑ 393 ‑‑ 352 ‑‑ 181 ‑‑ 626
West ‑‑ 1,186 ‑‑ 964 ‑‑ 379 ‑‑ 1,805
Mountain ‑‑ 545 ‑‑ 294 ‑‑ 100 ‑‑ 747
Pacific ‑‑ 641 ‑‑ 671 ‑‑ 280 ‑‑ 1,058
COUNTY TYPE                
Large Metro ‑‑ 2,374 ‑‑ 2,076 ‑‑ 792 ‑‑ 3,730
Small Metro ‑‑ 1,919 ‑‑ 1,318 ‑‑ 530 ‑‑ 2,813
Nonmetro ‑‑ 833 ‑‑ 372 ‑‑ 204 ‑‑ 1,010
Urbanized ‑‑ 300 ‑‑ 184 ‑‑ 99 ‑‑ 389
Less Urbanized ‑‑ 376 ‑‑ 153 ‑‑ 87 ‑‑ 446
Completely Rural ‑‑ 157 ‑‑ 36 ‑‑ 18 ‑‑ 175
POVERTY LEVEL3                
Less Than 100% ‑‑ 1,844 ‑‑ 883 ‑‑ 458 ‑‑ 2,298
100‑199% ‑‑ 1,341 ‑‑ 826 ‑‑ 322 ‑‑ 1,908
200% or More ‑‑ 1,938 ‑‑ 2,055 ‑‑ 745 ‑‑ 3,343
HEALTH INSURANCE4                
Private ‑‑ 1,751 ‑‑ 1,687 ‑‑ 564 ‑‑ 2,938
Medicaid/CHIP ‑‑ 2,475 ‑‑ 1,335 ‑‑ 643 ‑‑ 3,241
Other5 ‑‑ 1,082 ‑‑ 1,006 ‑‑ 386 ‑‑ 1,718
No Coverage ‑‑ 516 ‑‑ 389 ‑‑ 203 ‑‑ 746

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown information for the specific substance(s) for which they received substance use treatment were excluded from the respective analyses.

2 Includes data from respondents who were classified as having received substance use treatment but had unknown information regarding whether they received treatment specifically for drugs or alcohol.

3 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

5 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.18B – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Treatment for Drugs1
(2024)		 Treatment for Drugs1
(2025)		 Treatment for Alcohol1
(2024)		 Treatment for Alcohol1
(2025)		 Treatment for Both Drugs and Alcohol1
(2024)		 Treatment for Both Drugs and Alcohol1
(2025)		 Treatment for Substance Use2
(2024)		 Treatment for Substance Use2
(2025)
TOTAL ‑‑ 1.8 ‑‑ 1.3 ‑‑ 0.5 ‑‑ 2.6
GEOGRAPHIC DIVISION                
Northeast ‑‑ 2.0 ‑‑ 1.5 ‑‑ 0.6 ‑‑ 2.9
New England ‑‑ 1.7 ‑‑ 1.2 ‑‑ 0.5 ‑‑ 2.5
Middle Atlantic ‑‑ 2.2 ‑‑ 1.6 ‑‑ 0.7 ‑‑ 3.1
Midwest ‑‑ 1.9 ‑‑ 1.4 ‑‑ 0.5 ‑‑ 2.9
East North Central ‑‑ 2.1 ‑‑ 1.6 ‑‑ 0.5 ‑‑ 3.2
West North Central ‑‑ 1.4 ‑‑ 1.1 ‑‑ 0.4 ‑‑ 2.2
South ‑‑ 1.6 ‑‑ 1.1 ‑‑ 0.5 ‑‑ 2.3
South Atlantic ‑‑ 1.8 ‑‑ 1.2 ‑‑ 0.5 ‑‑ 2.4
East South Central ‑‑ 2.2 ‑‑ 0.9 ‑‑ 0.4 ‑‑ 2.7
West South Central ‑‑ 1.1 ‑‑ 1.0 ‑‑ 0.5 ‑‑ 1.7
West ‑‑ 1.7 ‑‑ 1.4 ‑‑ 0.6 ‑‑ 2.6
Mountain ‑‑ 2.4 ‑‑ 1.3 ‑‑ 0.4 ‑‑ 3.3
Pacific ‑‑ 1.4 ‑‑ 1.5 ‑‑ 0.6 ‑‑ 2.3
COUNTY TYPE                
Large Metro ‑‑ 1.4 ‑‑ 1.3 ‑‑ 0.5 ‑‑ 2.2
Small Metro ‑‑ 2.1 ‑‑ 1.4 ‑‑ 0.6 ‑‑ 3.1
Nonmetro ‑‑ 2.5 ‑‑ 1.1 ‑‑ 0.6 ‑‑ 3.0
Urbanized ‑‑ 2.5 ‑‑ 1.5 ‑‑ 0.8 ‑‑ 3.2
Less Urbanized ‑‑ 2.8 ‑‑ 1.1 ‑‑ 0.6 ‑‑ 3.3
Completely Rural ‑‑ 2.0 ‑‑ 0.5 ‑‑ 0.2 ‑‑ 2.2
POVERTY LEVEL3                
Less Than 100% ‑‑ 3.8 ‑‑ 1.8 ‑‑ 0.9 ‑‑ 4.7
100‑199% ‑‑ 2.2 ‑‑ 1.4 ‑‑ 0.5 ‑‑ 3.1
200% or More ‑‑ 1.1 ‑‑ 1.1 ‑‑ 0.4 ‑‑ 1.9
HEALTH INSURANCE4                
Private ‑‑ 1.0 ‑‑ 1.0 ‑‑ 0.3 ‑‑ 1.7
Medicaid/CHIP ‑‑ 4.1 ‑‑ 2.2 ‑‑ 1.1 ‑‑ 5.3
Other5 ‑‑ 1.3 ‑‑ 1.2 ‑‑ 0.5 ‑‑ 2.1
No Coverage ‑‑ 2.1 ‑‑ 1.6 ‑‑ 0.8 ‑‑ 3.0

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown information for the specific substance(s) for which they received substance use treatment were excluded from the respective analyses.

2 Includes data from respondents who were classified as having received substance use treatment but had unknown information regarding whether they received treatment specifically for drugs or alcohol.

3 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

5 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.19A – Substances for Which Treatment Was Received as an Inpatient in Past Year: Among People Aged 12 or Older Who Received Substance Use Treatment as an Inpatient in Past Year; by Age Group, Numbers in Thousands, 2024 and 2025
Substance for Which Treatment Was Received1 Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
INPATIENT SUBSTANCE USE TREATMENT2 ‑‑ 2,177 ‑‑ 106 ‑‑ 2,071 ‑‑ 279 ‑‑ 1,792
DRUGS ‑‑ 1,211 ‑‑ * ‑‑ 1,126 ‑‑ * ‑‑ 951
Marijuana ‑‑ 387 ‑‑ * ‑‑ 315 ‑‑ 72 ‑‑ 244
Cocaine ‑‑ 308 ‑‑ * ‑‑ 306 ‑‑ * ‑‑ 283
Heroin ‑‑ 262 ‑‑ * ‑‑ 262 ‑‑ * ‑‑ 251
Hallucinogens ‑‑ 90 ‑‑ * ‑‑ 84 ‑‑ * ‑‑ 48
Inhalants ‑‑ 95 ‑‑ * ‑‑ 89 ‑‑ 12 ‑‑ 78
Methamphetamine ‑‑ 413 ‑‑ * ‑‑ 413 ‑‑ * ‑‑ 374
Prescription Psychotherapeutics ‑‑ 456 ‑‑ * ‑‑ 446 ‑‑ * ‑‑ 347
Pain Relievers ‑‑ 368 ‑‑ * ‑‑ 362 ‑‑ * ‑‑ 276
Stimulants ‑‑ 60 ‑‑ * ‑‑ 51 ‑‑ 12 ‑‑ *
Tranquilizers or Sedatives ‑‑ 144 ‑‑ * ‑‑ 139 ‑‑ * ‑‑ 105
Tranquilizers ‑‑ 87 ‑‑ <1 ‑‑ 87 ‑‑ * ‑‑ 54
Sedatives ‑‑ 71 ‑‑ * ‑‑ 66 ‑‑ 3 ‑‑ 63
Opioids ‑‑ 527 ‑‑ * ‑‑ 521 ‑‑ * ‑‑ 428
Central Nervous System Stimulants ‑‑ 678 ‑‑ * ‑‑ 668 ‑‑ * ‑‑ 606
ALCOHOL ‑‑ 1,189 ‑‑ * ‑‑ 1,163 ‑‑ * ‑‑ 1,021
BOTH DRUGS AND ALCOHOL ‑‑ 328 ‑‑ * ‑‑ 312 ‑‑ 42 ‑‑ 270

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Respondents with unknown information for the specific substance(s) for which they received substance use treatment were excluded from the respective analyses.

1 Respondents could indicate multiple substances for which they received substance use treatment; thus, these response categories are not mutually exclusive.

2 Includes data from respondents who were classified as having received substance use treatment but had unknown information regarding whether they received treatment specifically for drugs or alcohol.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.19B – Substances for Which Treatment Was Received as an Inpatient in Past Year: Among People Aged 12 or Older Who Received Substance Use Treatment as an Inpatient in Past Year; by Age Group, Percentages, 2024 and 2025
Substance for Which Treatment Was Received1 Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
INPATIENT SUBSTANCE USE TREATMENT2 ‑‑ 100.0 ‑‑ 100.0 ‑‑ 100.0 ‑‑ 100.0 ‑‑ 100.0
DRUGS ‑‑ 58.1 ‑‑ * ‑‑ 56.8 ‑‑ * ‑‑ 55.7
Marijuana ‑‑ 18.5 ‑‑ * ‑‑ 15.9 ‑‑ 26.1 ‑‑ 14.3
Cocaine ‑‑ 14.6 ‑‑ * ‑‑ 15.3 ‑‑ * ‑‑ 16.4
Heroin ‑‑ 12.4 ‑‑ * ‑‑ 13.0 ‑‑ * ‑‑ 14.4
Hallucinogens ‑‑ 4.3 ‑‑ * ‑‑ 4.2 ‑‑ * ‑‑ 2.8
Inhalants ‑‑ 4.5 ‑‑ * ‑‑ 4.4 ‑‑ 4.2 ‑‑ 4.5
Methamphetamine ‑‑ 19.6 ‑‑ * ‑‑ 20.6 ‑‑ * ‑‑ 21.8
Prescription Psychotherapeutics ‑‑ 22.6 ‑‑ * ‑‑ 23.3 ‑‑ * ‑‑ 21.2
Pain Relievers ‑‑ 18.0 ‑‑ * ‑‑ 18.7 ‑‑ * ‑‑ 16.6
Stimulants ‑‑ 2.9 ‑‑ * ‑‑ 2.6 ‑‑ 4.2 ‑‑ *
Tranquilizers or Sedatives ‑‑ 6.9 ‑‑ * ‑‑ 7.0 ‑‑ * ‑‑ 6.2
Tranquilizers ‑‑ 4.2 ‑‑ 0.1 ‑‑ 4.4 ‑‑ * ‑‑ 3.1
Sedatives ‑‑ 3.3 ‑‑ * ‑‑ 3.2 ‑‑ 1.2 ‑‑ 3.6
Opioids ‑‑ 25.8 ‑‑ * ‑‑ 26.9 ‑‑ * ‑‑ 25.8
Central Nervous System Stimulants ‑‑ 32.8 ‑‑ * ‑‑ 34.1 ‑‑ * ‑‑ 36.0
ALCOHOL ‑‑ 56.9 ‑‑ * ‑‑ 58.6 ‑‑ * ‑‑ 59.8
BOTH DRUGS AND ALCOHOL ‑‑ 15.7 ‑‑ * ‑‑ 15.8 ‑‑ 15.4 ‑‑ 15.8

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Respondents with unknown information for the specific substance(s) for which they received substance use treatment were excluded from the respective analyses.

1 Respondents could indicate multiple substances for which they received substance use treatment; thus, these response categories are not mutually exclusive.

2 Includes data from respondents who were classified as having received substance use treatment but had unknown information regarding whether they received treatment specifically for drugs or alcohol.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.20A – Substances for Which Treatment Was Received as an Outpatient in Past Year: Among People Aged 12 or Older Who Received Substance Use Treatment as an Outpatient in Past Year; by Age Group, Numbers in Thousands, 2024 and 2025
Substance for Which Treatment Was Received1 Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
OUTPATIENT SUBSTANCE USE TREATMENT2 ‑‑ 4,416 ‑‑ 203 ‑‑ 4,213 ‑‑ 524 ‑‑ 3,689
DRUGS ‑‑ 3,029 ‑‑ * ‑‑ 2,863 ‑‑ 387 ‑‑ 2,477
Marijuana ‑‑ 942 ‑‑ * ‑‑ 824 ‑‑ 256 ‑‑ 568
Cocaine ‑‑ 581 ‑‑ * ‑‑ 573 ‑‑ 28 ‑‑ 546
Heroin ‑‑ 644 ‑‑ * ‑‑ 644 ‑‑ 7 ‑‑ 637
Hallucinogens ‑‑ 187 ‑‑ * ‑‑ 169 ‑‑ * ‑‑ 125
Inhalants ‑‑ 73 ‑‑ * ‑‑ 58 ‑‑ 11 ‑‑ 48
Methamphetamine ‑‑ 740 ‑‑ * ‑‑ 733 ‑‑ * ‑‑ 690
Prescription Psychotherapeutics ‑‑ 1,394 ‑‑ * ‑‑ 1,344 ‑‑ 124 ‑‑ 1,220
Pain Relievers ‑‑ 1,075 ‑‑ 13 ‑‑ 1,062 ‑‑ 75 ‑‑ 988
Stimulants ‑‑ 287 ‑‑ * ‑‑ 253 ‑‑ 34 ‑‑ 218
Tranquilizers or Sedatives ‑‑ 367 ‑‑ * ‑‑ 355 ‑‑ * ‑‑ 300
Tranquilizers ‑‑ 302 ‑‑ * ‑‑ 295 ‑‑ * ‑‑ 244
Sedatives ‑‑ 154 ‑‑ * ‑‑ 148 ‑‑ 6 ‑‑ 143
Opioids ‑‑ 1,405 ‑‑ 13 ‑‑ 1,392 ‑‑ 77 ‑‑ 1,315
Central Nervous System Stimulants ‑‑ 1,401 ‑‑ * ‑‑ 1,362 ‑‑ 97 ‑‑ 1,265
ALCOHOL ‑‑ 1,874 ‑‑ * ‑‑ 1,810 ‑‑ 205 ‑‑ 1,605
BOTH DRUGS AND ALCOHOL ‑‑ 715 ‑‑ * ‑‑ 669 ‑‑ 91 ‑‑ 578

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Respondents with unknown information for the specific substance(s) for which they received substance use treatment were excluded from the respective analyses.

1 Respondents could indicate multiple substances for which they received substance use treatment; thus, these response categories are not mutually exclusive.

2 Includes data from respondents who were classified as having received substance use treatment but had unknown information regarding whether they received treatment specifically for drugs or alcohol.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.20B – Substances for Which Treatment Was Received as an Outpatient in Past Year: Among People Aged 12 or Older Who Received Substance Use Treatment as an Outpatient in Past Year; by Age Group, Percentages, 2024 and 2025
Substance for Which Treatment Was Received1 Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
OUTPATIENT SUBSTANCE USE TREATMENT2 ‑‑ 100.0 ‑‑ 100.0 ‑‑ 100.0 ‑‑ 100.0 ‑‑ 100.0
DRUGS ‑‑ 71.2 ‑‑ * ‑‑ 70.5 ‑‑ 77.2 ‑‑ 69.6
Marijuana ‑‑ 22.0 ‑‑ * ‑‑ 20.2 ‑‑ 50.5 ‑‑ 15.9
Cocaine ‑‑ 13.4 ‑‑ * ‑‑ 13.9 ‑‑ 5.3 ‑‑ 15.1
Heroin ‑‑ 14.8 ‑‑ * ‑‑ 15.6 ‑‑ 1.4 ‑‑ 17.6
Hallucinogens ‑‑ 4.3 ‑‑ * ‑‑ 4.1 ‑‑ * ‑‑ 3.5
Inhalants ‑‑ 1.7 ‑‑ * ‑‑ 1.4 ‑‑ 2.0 ‑‑ 1.3
Methamphetamine ‑‑ 17.1 ‑‑ * ‑‑ 17.8 ‑‑ * ‑‑ 19.1
Prescription Psychotherapeutics ‑‑ 33.0 ‑‑ * ‑‑ 33.3 ‑‑ 24.9 ‑‑ 34.5
Pain Relievers ‑‑ 25.3 ‑‑ 6.7 ‑‑ 26.2 ‑‑ 14.8 ‑‑ 27.9
Stimulants ‑‑ 6.6 ‑‑ * ‑‑ 6.1 ‑‑ 6.6 ‑‑ 6.1
Tranquilizers or Sedatives ‑‑ 8.6 ‑‑ * ‑‑ 8.7 ‑‑ * ‑‑ 8.4
Tranquilizers ‑‑ 7.0 ‑‑ * ‑‑ 7.2 ‑‑ * ‑‑ 6.8
Sedatives ‑‑ 3.6 ‑‑ * ‑‑ 3.6 ‑‑ 1.2 ‑‑ 4.0
Opioids ‑‑ 33.1 ‑‑ 6.7 ‑‑ 34.4 ‑‑ 15.2 ‑‑ 37.1
Central Nervous System Stimulants ‑‑ 32.6 ‑‑ * ‑‑ 33.2 ‑‑ 19.0 ‑‑ 35.2
ALCOHOL ‑‑ 44.4 ‑‑ * ‑‑ 45.0 ‑‑ 40.5 ‑‑ 45.6
BOTH DRUGS AND ALCOHOL ‑‑ 16.8 ‑‑ * ‑‑ 16.5 ‑‑ 18.3 ‑‑ 16.2

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Respondents with unknown information for the specific substance(s) for which they received substance use treatment were excluded from the respective analyses.

1 Respondents could indicate multiple substances for which they received substance use treatment; thus, these response categories are not mutually exclusive.

2 Includes data from respondents who were classified as having received substance use treatment but had unknown information regarding whether they received treatment specifically for drugs or alcohol.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.21A – Received Medications for Alcohol Use Disorder (MAUD) in Past Year: Among People Aged 12 or Older; Received MAUD in Past Year: Among People Aged 12 or Older with Past Year Alcohol Use Disorder; by Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Received MAUD
(2024)		 Received MAUD
(2025)		 Received MAUD among People with an Alcohol Use Disorder1
(2024)		 Received MAUD among People with an Alcohol Use Disorder1
(2025)
TOTAL 1,309 1,141 697 679
AGE GROUP        
12‑17 51 26 33 *
18 or Older 1,258 1,115 665 663
18‑25 123b 49 86b 21
26 or Older 1,136 1,066 579 643
SEX        
Male 836 647 446 356
Female 473 494 251 323
HISPANIC ORIGIN AND RACE        
Not Hispanic or Latino 1,100 877 588 502
AIAN 15 14 4 6
Asian 4 2 * *
Black or African American 218 227 62 127
NHPI 1 2 * *
White 849 602 506 350
Two or More Races 12 31 12 *
Hispanic or Latino 210 264 109 177

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Medications for alcohol use disorder (MAUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of alcohol.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Alcohol use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.21B – Received Medications for Alcohol Use Disorder (MAUD) in Past Year: Among People Aged 12 or Older; Received MAUD in Past Year: Among People Aged 12 or Older with Past Year Alcohol Use Disorder; by Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Received MAUD
(2024)		 Received MAUD
(2025)		 Received MAUD among People with an Alcohol Use Disorder1
(2024)		 Received MAUD among People with an Alcohol Use Disorder1
(2025)
TOTAL 0.5 0.4 2.5 2.6
AGE GROUP        
12‑17 0.2 0.1 4.2 *
18 or Older 0.5 0.4 2.4 2.6
18‑25 0.4b 0.1 1.7b 0.4
26 or Older 0.5 0.5 2.6 3.2
SEX        
Male 0.6 0.5 2.7 2.3
Female 0.3 0.3 2.2 3.1
HISPANIC ORIGIN AND RACE        
Not Hispanic or Latino 0.5 0.4 2.6 2.5
AIAN 1.1 0.7 2.8 4.1
Asian <0.1 <0.1 * *
Black or African American 0.6 0.7 1.8 4.3
NHPI 0.1 0.1 * *
White 0.5 0.4 2.9 2.3
Two or More Races 0.2 0.3 1.8 *
Hispanic or Latino 0.4 0.5 2.2 3.3

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Medications for alcohol use disorder (MAUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of alcohol.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Alcohol use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.22A – Received Medications for Opioid Use Disorder (MOUD) in Past Year: Among People Aged 12 or Older; Received MOUD in Past Year: Among People Aged 12 or Older with Past Year Opioid Use Disorder; by Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Received MOUD
(2024)		 Received MOUD
(2025)		 Received MOUD among People with an Opioid Use Disorder1
(2024)		 Received MOUD among People with an Opioid Use Disorder1
(2025)
TOTAL 2,155 2,132 818 623
AGE GROUP        
12‑17 36 37 15 *
18 or Older 2,119 2,095 803 616
18‑25 68 80 42 *
26 or Older 2,051 2,015 760 579
SEX        
Male 1,170 1,001 453 324
Female 984 1,131 365 299
HISPANIC ORIGIN AND RACE        
Not Hispanic or Latino 1,952 1,927 707 534
AIAN 31 23 * *
Asian 12 65 * *
Black or African American 212 136 56 *
NHPI * * * *
White 1,644 1,607 622a 381
Two or More Races 49 92 * *
Hispanic or Latino 202 205 110 *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Medications for opioid use disorder (MOUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of opioids. Questions for the receipt of MOUD were asked only if respondents reported lifetime use of heroin or prescription pain relievers.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Opioid use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on opioid use disorder.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.22B – Received Medications for Opioid Use Disorder (MOUD) in Past Year: Among People Aged 12 or Older; Received MOUD in Past Year: Among People Aged 12 or Older with Past Year Opioid Use Disorder; by Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Received MOUD
(2024)		 Received MOUD
(2025)		 Received MOUD among People with an Opioid Use Disorder1
(2024)		 Received MOUD among People with an Opioid Use Disorder1
(2025)
TOTAL 0.7 0.7 17.0 15.7
AGE GROUP        
12‑17 0.1 0.1 5.6 *
18 or Older 0.8 0.8 17.6 16.4
18‑25 0.2 0.2 12.6 *
26 or Older 0.9 0.9 18.0 16.9
SEX        
Male 0.8 0.7 19.3 16.8
Female 0.7 0.8 14.7 14.7
HISPANIC ORIGIN AND RACE        
Not Hispanic or Latino 0.8 0.8 17.7 16.7
AIAN 2.3 1.2 * *
Asian 0.1 0.3 * *
Black or African American 0.6 0.4 12.3 *
NHPI * * * *
White 1.0 1.0 19.9 16.7
Two or More Races 0.7 1.0 * *
Hispanic or Latino 0.4 0.4 13.5 *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Medications for opioid use disorder (MOUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of opioids. Questions for the receipt of MOUD were asked only if respondents reported lifetime use of heroin or prescription pain relievers.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Opioid use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on opioid use disorder.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.23A – Received Medications for Alcohol Use Disorder (MAUD) in Past Year: Among People Aged 12 or Older; Received MAUD in Past Year: Among People Aged 12 or Older with Past Year Alcohol Use Disorder; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Received MAUD
(2024)		 Received MAUD
(2025)		 Received MAUD among People with an Alcohol Use Disorder1
(2024)		 Received MAUD among People with an Alcohol Use Disorder1
(2025)
TOTAL 1,309 1,141 697 679
GEOGRAPHIC DIVISION        
Northeast 211 241 166 118
New England 33 46 18 31
Middle Atlantic 178 195 147 87
Midwest 214 242 122 153
East North Central 183 190 104 122
West North Central 31 52 18 31
South 577 371 238 269
South Atlantic 359 223 122 159
East South Central 35 50 15 44
West South Central 183 98 102 66
West 307 286 172 138
Mountain 68 71 51 29
Pacific 240 215 121 109
COUNTY TYPE        
Large Metro 915 631 500 422
Small Metro 312 381 159 207
Nonmetro 81 129 38 51
Urbanized 24 72 15a 4
Less Urbanized 31 42 15 38
Completely Rural 26 16 8 8
POVERTY LEVEL2        
Less Than 100% 297 204 127 123
100‑199% 245 193 133 132
200% or More 767 744 438 424
HEALTH INSURANCE3        
Private 778 609 461 342
Medicaid/CHIP 329 345 122 250
Other4 386 320 164 152
No Coverage 92 110 61 70

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Medications for alcohol use disorder (MAUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of alcohol.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Alcohol use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder.

2 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

4 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.23B – Received Medications for Alcohol Use Disorder (MAUD) in Past Year: Among People Aged 12 or Older; Received MAUD in Past Year: Among People Aged 12 or Older with Past Year Alcohol Use Disorder; by Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Received MAUD
(2024)		 Received MAUD
(2025)		 Received MAUD among People with an Alcohol Use Disorder1
(2024)		 Received MAUD among People with an Alcohol Use Disorder1
(2025)
TOTAL 0.5 0.4 2.5 2.6
GEOGRAPHIC DIVISION        
Northeast 0.4 0.5 3.5 2.7
New England 0.2 0.3 1.4 2.2
Middle Atlantic 0.5 0.5 4.3 3.0
Midwest 0.4 0.4 1.9 2.7
East North Central 0.5 0.5 2.3 3.0
West North Central 0.2 0.3 1.0 2.0
South 0.5 0.3 2.4 2.9
South Atlantic 0.6 0.4 2.3 3.3
East South Central 0.2 0.3 1.0 3.3
West South Central 0.5 0.3 3.2 2.1
West 0.5 0.4 2.5 2.2
Mountain 0.3 0.3 2.2 1.4
Pacific 0.5 0.5 2.6 2.6
COUNTY TYPE        
Large Metro 0.6 0.4 3.0 2.8
Small Metro 0.4 0.4 1.9 2.5
Nonmetro 0.2 0.4 1.4 2.1
Urbanized 0.2 0.6 1.3 0.5
Less Urbanized 0.3 0.3 1.4 3.6
Completely Rural 0.3 0.2 1.4 1.7
POVERTY LEVEL2        
Less Than 100% 0.6 0.4 2.8 2.9
100‑199% 0.4 0.3 2.9 2.6
200% or More 0.4 0.4 2.3 2.6
HEALTH INSURANCE3        
Private 0.4 0.4 2.7 2.2
Medicaid/CHIP 0.6 0.6 2.3 4.4
Other4 0.5 0.4 3.5 3.2
No Coverage 0.4 0.4 1.9 2.3

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Medications for alcohol use disorder (MAUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of alcohol.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Alcohol use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder.

2 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

4 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.24A – Received Medications for Opioid Use Disorder (MOUD) in Past Year: Among People Aged 12 or Older; Received MOUD in Past Year: Among People Aged 12 or Older with Past Year Opioid Use Disorder; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Received MOUD
(2024)		 Received MOUD
(2025)		 Received MOUD among People with an Opioid Use Disorder1
(2024)		 Received MOUD among People with an Opioid Use Disorder1
(2025)
TOTAL 2,155 2,132 818 623
GEOGRAPHIC DIVISION        
Northeast 494 679 204 *
New England 112 130 * *
Middle Atlantic 382 549 155 *
Midwest 385 453 183 97
East North Central 331 404 162 *
West North Central 54 49 21 *
South 823 697 281 236
South Atlantic 389 374 124 137
East South Central 227 248 * *
West South Central 206b 74 67a 15
West 453 303 150 87
Mountain 147 109 * 19
Pacific 306 194 * *
COUNTY TYPE        
Large Metro 1,021 885 350 272
Small Metro 870 844 326 221
Nonmetro 264 403 142 *
Urbanized 85 170 25 *
Less Urbanized 107 117 * *
Completely Rural 72 117 * *
POVERTY LEVEL2        
Less Than 100% 728 892 322 330
100‑199% 472 494 181 132
200% or More 955 746 315a 161
HEALTH INSURANCE3        
Private 863a 551 277a 106
Medicaid/CHIP 1,123 1,170 497 431
Other4 389 521 100 68
No Coverage 118 157 * *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Medications for opioid use disorder (MOUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of opioids. Questions for the receipt of MOUD were asked only if respondents reported lifetime use of heroin or prescription pain relievers.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Opioid use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on opioid use disorder.

2 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

4 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.24B – Received Medications for Opioid Use Disorder (MOUD) in Past Year: Among People Aged 12 or Older; Received MOUD in Past Year: Among People Aged 12 or Older with Past Year Opioid Use Disorder; by Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Received MOUD
(2024)		 Received MOUD
(2025)		 Received MOUD among People with an Opioid Use Disorder1
(2024)		 Received MOUD among People with an Opioid Use Disorder1
(2025)
TOTAL 0.7 0.7 17.0 15.7
GEOGRAPHIC DIVISION        
Northeast 1.0 1.4 25.5 *
New England 0.8 1.0 * *
Middle Atlantic 1.1 1.5 23.2 *
Midwest 0.7 0.8 18.9 14.4
East North Central 0.8 1.0 23.1 *
West North Central 0.3 0.3 7.8 *
South 0.7 0.6 15.1 14.6
South Atlantic 0.7 0.6 13.6 15.5
East South Central 1.4 1.5 * *
West South Central 0.6b 0.2 11.3 3.5
West 0.7 0.4 12.5 8.9
Mountain 0.7 0.5 * 4.8
Pacific 0.7 0.4 * *
COUNTY TYPE        
Large Metro 0.6 0.5 14.0 13.4
Small Metro 1.0 0.9 21.2 16.7
Nonmetro 0.8 1.2 18.0 *
Urbanized 0.6 1.4 10.0 *
Less Urbanized 0.9 0.9 * *
Completely Rural 0.9 1.5 * *
POVERTY LEVEL2        
Less Than 100% 1.6 1.8 21.1 25.3
100‑199% 0.8 0.8 14.4 10.7
200% or More 0.5 0.4 15.4 11.2
HEALTH INSURANCE3        
Private 0.5a 0.3 14.6 7.8
Medicaid/CHIP 1.9 1.9 24.2 23.4
Other4 0.5 0.6 5.4 5.0
No Coverage 0.5 0.6 * *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Medications for opioid use disorder (MOUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of opioids. Questions for the receipt of MOUD were asked only if respondents reported lifetime use of heroin or prescription pain relievers.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Opioid use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on opioid use disorder.

2 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

4 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.25A – Received Substance Use Treatment through Telehealth: Among People Aged 12 or Older with Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year; by Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Received Telehealth Treatment for Drug Use among People with a Drug Use Disorder1
(2024)		 Received Telehealth Treatment for Drug Use among People with a Drug Use Disorder1
(2025)		 Received Telehealth Treatment for Alcohol Use among People with an Alcohol Use Disorder1
(2024)		 Received Telehealth Treatment for Alcohol Use among People with an Alcohol Use Disorder1
(2025)		 Received Telehealth Treatment for Substance Use among People with a Substance Use Disorder2
(2024)		 Received Telehealth Treatment for Substance Use among People with a Substance Use Disorder2
(2025)
TOTAL 1,490 1,646 1,134 1,053 2,628 2,526
AGE GROUP            
12‑17 65a 148 32 34 77a 167
18 or Older 1,425 1,498 1,101 1,019 2,551 2,360
18‑25 213 225 127 142 323 308
26 or Older 1,213 1,274 974 878 2,227 2,052
SEX            
Male 865 775 622 595 1,456 1,258
Female 625 871 512 458 1,172 1,268
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 1,292 1,389 960 823 2,251 2,073
AIAN 16 * 5 * 18 19
Asian 22 4 * 2 46 6
Black or African American 135 83 129 130 274 205
NHPI * * * * * *
White 1,072 1,152 776 568 1,828 1,674
Two or More Races 38 * 11 * 75 168
Hispanic or Latino 198 257 174 230 377 453

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown information for the specific substance(s) for which they received substance use treatment were excluded from the respective analyses.

2 Includes data from respondents who were classified as having received substance use treatment but had unknown information regarding whether they received treatment specifically for drugs or alcohol.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.25B – Received Substance Use Treatment through Telehealth: Among People Aged 12 or Older with Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year; by Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Received Telehealth Treatment for Drug Use among People with a Drug Use Disorder1
(2024)		 Received Telehealth Treatment for Drug Use among People with a Drug Use Disorder1
(2025)		 Received Telehealth Treatment for Alcohol Use among People with an Alcohol Use Disorder1
(2024)		 Received Telehealth Treatment for Alcohol Use among People with an Alcohol Use Disorder1
(2025)		 Received Telehealth Treatment for Substance Use among People with a Substance Use Disorder2
(2024)		 Received Telehealth Treatment for Substance Use among People with a Substance Use Disorder2
(2025)
TOTAL 5.3 6.3 4.1 4.1 5.4 5.7
AGE GROUP            
12‑17 3.8b 9.8 4.2 4.8 3.8b 8.9
18 or Older 5.4 6.1 4.1 4.1 5.5 5.5
18‑25 3.4 3.9 2.5 3.0 3.6 3.6
26 or Older 6.0 6.8 4.4 4.3 6.0 6.0
SEX            
Male 5.4 5.4 3.7 3.9 5.2 4.9
Female 5.2 7.5 4.6 4.5 5.8 6.7
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 5.5 6.7 4.2 4.1 5.6 5.8
AIAN 7.6 * 3.6 * 6.2 5.3
Asian 3.0 0.6 * 0.2 2.8 0.4
Black or African American 3.4 2.2 3.8 4.4 4.5 3.6
NHPI * * * * * *
White 6.2 7.8 4.4 3.7 6.0 6.4
Two or More Races 3.4 * 1.7 * 5.1 8.5
Hispanic or Latino 4.1 5.0 3.5 4.2 4.5 5.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown information for the specific substance(s) for which they received substance use treatment were excluded from the respective analyses.

2 Includes data from respondents who were classified as having received substance use treatment but had unknown information regarding whether they received treatment specifically for drugs or alcohol.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.26A – Received Substance Use Treatment through Telehealth: Among People Aged 12 or Older with Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic Received Telehealth Treatment for Drug Use among People with a Drug Use Disorder1
(2024)		 Received Telehealth Treatment for Drug Use among People with a Drug Use Disorder1
(2025)		 Received Telehealth Treatment for Alcohol Use among People with an Alcohol Use Disorder1
(2024)		 Received Telehealth Treatment for Alcohol Use among People with an Alcohol Use Disorder1
(2025)		 Received Telehealth Treatment for Substance Use among People with a Substance Use Disorder2
(2024)		 Received Telehealth Treatment for Substance Use among People with a Substance Use Disorder2
(2025)
TOTAL 1,490 1,646 1,134 1,053 2,628 2,526
GEOGRAPHIC DIVISION            
Northeast 341 482 164 196 523 651
New England 87 103 45 52 163 139
Middle Atlantic 254 378 119 144 360 512
Midwest 327 282 219 210 507 466
East North Central 230 222 153 187 375 388
West North Central 97 59 66 23 133 78
South 483 422 439 324 939 715
South Atlantic 242 295 225 256 478 485
East South Central 125 87 75 24 188 124
West South Central 117a 39 140a 44 273a 105
West 340 461 311 324 659 694
Mountain 83 207 98 70 164 270
Pacific 257 255 213 254 494 424
COUNTY TYPE            
Large Metro 802 819 693 718 1,536 1,363
Small Metro 444 609 305 253 744 870
Nonmetro 244 218 136 82 348 293
Urbanized 58 75 41 40 82 93
Less Urbanized 110 90 70 29 163 136
Completely Rural 76 * 24 13 102 64
POVERTY LEVEL3            
Less Than 100% 599 530 196 148 813 674
100‑199% 284 532 190 254 473 696
200% or More 607 583 747 650 1,342 1,154
HEALTH INSURANCE4            
Private 598 492 641 466 1,198 954
Medicaid/CHIP 775 868 277 359 1,104 1,099
Other5 337 351 277 222 580 474
No Coverage 106 107 93 174 199 241

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown information for the specific substance(s) for which they received substance use treatment were excluded from the respective analyses.

2 Includes data from respondents who were classified as having received substance use treatment but had unknown information regarding whether they received treatment specifically for drugs or alcohol.

3 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

5 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.26B – Received Substance Use Treatment through Telehealth: Among People Aged 12 or Older with Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year; by Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic Received Telehealth Treatment for Drug Use among People with a Drug Use Disorder1
(2024)		 Received Telehealth Treatment for Drug Use among People with a Drug Use Disorder1
(2025)		 Received Telehealth Treatment for Alcohol Use among People with an Alcohol Use Disorder1
(2024)		 Received Telehealth Treatment for Alcohol Use among People with an Alcohol Use Disorder1
(2025)		 Received Telehealth Treatment for Substance Use among People with a Substance Use Disorder2
(2024)		 Received Telehealth Treatment for Substance Use among People with a Substance Use Disorder2
(2025)
TOTAL 5.3 6.3 4.1 4.1 5.4 5.7
GEOGRAPHIC DIVISION            
Northeast 6.9 10.9 3.5 4.5 6.2 8.6
New England 6.1 7.7 3.4 3.8 6.6 5.9
Middle Atlantic 7.2 12.3 3.5 4.9 6.0 9.8
Midwest 5.4 4.8 3.5 3.7 4.8 4.6
East North Central 5.4 5.5 3.5 4.6 5.1 5.4
West North Central 5.3 3.3 3.7 1.5 4.3 2.6
South 4.8 4.7 4.4 3.4 5.4 4.5
South Atlantic 4.4 6.1 4.2 5.3 5.1 5.8
East South Central 8.1 6.4 5.1 1.8 7.3 5.1
West South Central 3.8a 1.4 4.5a 1.4 5.1a 2.1
West 4.9 7.0 4.5 5.1 5.5 6.4
Mountain 3.2a 9.4 4.2 3.3 3.9 7.1
Pacific 5.9 5.8 4.6 6.1 6.2 5.9
COUNTY TYPE            
Large Metro 5.1 5.6 4.1 4.8 5.5 5.4
Small Metro 5.1 7.2 3.7 3.1 5.1 6.0
Nonmetro 6.8 7.6 5.0 3.3 6.3 6.2
Urbanized 4.2 6.1 3.8 4.4 3.8 5.1
Less Urbanized 7.8 7.8 6.7 2.7 7.8 6.8
Completely Rural 9.5 * 4.1 2.8 8.1 7.2
POVERTY LEVEL3            
Less Than 100% 9.0 7.8 4.4 3.5 8.6 7.2
100‑199% 4.3 8.1 4.1 5.0 5.0 7.1
200% or More 4.1 4.7 4.0 4.0 4.6 4.6
HEALTH INSURANCE4            
Private 4.4 4.1 3.7 3.0 4.4 4.0
Medicaid/CHIP 8.3 9.5 5.1 6.4 8.8 8.9
Other5 6.8 7.8 5.8 4.7 6.6 5.8
No Coverage 2.9 3.4 2.9 5.8 3.6 4.7

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates.

NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Respondents with unknown information for the specific substance(s) for which they received substance use treatment were excluded from the respective analyses.

2 Includes data from respondents who were classified as having received substance use treatment but had unknown information regarding whether they received treatment specifically for drugs or alcohol.

3 Respondents aged 18 to 22 who were living in a college dormitory were excluded.

4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.

5 Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260615
Table 5.27A – Types and Locations of Substance Use Treatment and Other Services in Past Year: Among People Aged 12 or Older; by Age Group, Numbers in Thousands, 2024 and 2025
Type/Location of Treatment or Other Services Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
SUBSTANCE USE TREATMENT OR OTHER SERVICES1 ‑‑ 11,000 ‑‑ 671 ‑‑ 10,329 ‑‑ 1,105 ‑‑ 9,224
SUBSTANCE USE TREATMENT ‑‑ 7,554 ‑‑ 470 ‑‑ 7,083 ‑‑ 845 ‑‑ 6,238
Inpatient ‑‑ 2,177 ‑‑ 106 ‑‑ 2,071 ‑‑ 279 ‑‑ 1,792
Hospital ‑‑ 1,366 ‑‑ 47 ‑‑ 1,320 ‑‑ 184 ‑‑ 1,136
Residential Drug or Alcohol Rehab or Treatment Center ‑‑ 1,210 ‑‑ 21 ‑‑ 1,189 ‑‑ 122 ‑‑ 1,067
Residential Mental Health Treatment Center ‑‑ 901 ‑‑ 68 ‑‑ 833 ‑‑ 97 ‑‑ 736
Some Other Place as an Inpatient ‑‑ 488 ‑‑ 31 ‑‑ 457 ‑‑ 88 ‑‑ 369
Outpatient ‑‑ 4,416 ‑‑ 203 ‑‑ 4,213 ‑‑ 524 ‑‑ 3,689
Drug or Alcohol Rehab or Treatment Center ‑‑ 2,100 ‑‑ 43 ‑‑ 2,057 ‑‑ 184 ‑‑ 1,873
Mental Health Treatment Center ‑‑ 1,579 ‑‑ 51 ‑‑ 1,528 ‑‑ 153 ‑‑ 1,375
Office of a Therapist, Psychologist, Psychiatrist, or Substance Use Treatment Professional ‑‑ 2,991 ‑‑ 142 ‑‑ 2,848 ‑‑ 334 ‑‑ 2,514
General Medical Clinic or Doctor’s Office ‑‑ 1,866 ‑‑ 32 ‑‑ 1,835 ‑‑ 160 ‑‑ 1,674
Hospital ‑‑ 755 ‑‑ 29 ‑‑ 726 ‑‑ 101 ‑‑ 625
School’s Health or Counseling Center ‑‑ 366 ‑‑ 74 ‑‑ 292 ‑‑ 112 ‑‑ 180
Some Other Place as an Outpatient ‑‑ 678 ‑‑ 42 ‑‑ 636 ‑‑ 63 ‑‑ 573
Outpatient, Other Than General Medical Clinic or Doctor’s Office ‑‑ 4,073 ‑‑ 193 ‑‑ 3,879 ‑‑ 480 ‑‑ 3,399
Medications for Alcohol Use Disorder2 1,309 1,141 51 26 1,258 1,115 123b 49 1,136 1,066
Medications for Opioid Use Disorder3 2,155 2,132 36 37 2,119 2,095 68 80 2,051 2,015
Telehealth Treatment4 3,640 3,631 119a 238 3,521 3,393 377 374 3,143 3,019
Prison, Jail, or Juvenile Detention Center 819 649 41 50 779 598 63 71 716 527
OTHER SERVICES                    
Support Services                    
Support Group 6,104 5,749 170 223 5,934 5,526 456 396 5,478 5,130
Peer Support Specialist or Recovery Coach 2,244 2,261 50 85 2,194 2,176 161 186 2,033 1,990
Emergency Room/Department or Withdrawal Management Services                    
Emergency Room/Department 1,723 1,718 89 95 1,634 1,624 293 342 1,341 1,281
Withdrawal Management Services 955 1,137 30 19 925 1,118 89 77 836 1,041
Overdose Reversal Medicine (e.g., Narcan® or Naloxone) 1,753b 668 84a 39 1,669b 629 149a 72 1,520b 557

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.

NOTE: Respondents could indicate multiple types/locations for receiving substance use treatment or other services; thus, these response categories are not mutually exclusive.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes treatment for drug or alcohol use through support group services, peer support specialist or recovery coach services, treatment received in an emergency room/department, withdrawal management services, or overdose reversal medicine. Other services questions are asked of respondents who used drugs or alcohol in their lifetime.

2 Medications for alcohol use disorder (MAUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of alcohol.

3 Medications for opioid use disorder (MOUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of opioids. Questions for the receipt of MOUD were asked only if respondents reported lifetime use of heroin or prescription pain relievers.

4 Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260615
Table 5.27B – Types and Locations of Substance Use Treatment and Other Services in Past Year: Among People Aged 12 or Older; by Age Group, Percentages, 2024 and 2025
Type/Location of Treatment or Other Services Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
SUBSTANCE USE TREATMENT OR OTHER SERVICES1 ‑‑ 3.8 ‑‑ 2.6 ‑‑ 3.9 ‑‑ 3.1 ‑‑ 4.0
SUBSTANCE USE TREATMENT ‑‑ 2.6 ‑‑ 1.8 ‑‑ 2.7 ‑‑ 2.3 ‑‑ 2.7
Inpatient ‑‑ 0.7 ‑‑ 0.4 ‑‑ 0.8 ‑‑ 0.8 ‑‑ 0.8
Hospital ‑‑ 0.5 ‑‑ 0.2 ‑‑ 0.5 ‑‑ 0.5 ‑‑ 0.5
Residential Drug or Alcohol Rehab or Treatment Center ‑‑ 0.4 ‑‑ 0.1 ‑‑ 0.4 ‑‑ 0.3 ‑‑ 0.5
Residential Mental Health Treatment Center ‑‑ 0.3 ‑‑ 0.3 ‑‑ 0.3 ‑‑ 0.3 ‑‑ 0.3
Some Other Place as an Inpatient ‑‑ 0.2 ‑‑ 0.1 ‑‑ 0.2 ‑‑ 0.2 ‑‑ 0.2
Outpatient ‑‑ 1.5 ‑‑ 0.8 ‑‑ 1.6 ‑‑ 1.5 ‑‑ 1.6
Drug or Alcohol Rehab or Treatment Center ‑‑ 0.7 ‑‑ 0.2 ‑‑ 0.8 ‑‑ 0.5 ‑‑ 0.8
Mental Health Treatment Center ‑‑ 0.5 ‑‑ 0.2 ‑‑ 0.6 ‑‑ 0.4 ‑‑ 0.6
Office of a Therapist, Psychologist, Psychiatrist, or Substance Use Treatment Professional ‑‑ 1.0 ‑‑ 0.6 ‑‑ 1.1 ‑‑ 0.9 ‑‑ 1.1
General Medical Clinic or Doctor’s Office ‑‑ 0.6 ‑‑ 0.1 ‑‑ 0.7 ‑‑ 0.4 ‑‑ 0.7
Hospital ‑‑ 0.3 ‑‑ 0.1 ‑‑ 0.3 ‑‑ 0.3 ‑‑ 0.3
School’s Health or Counseling Center ‑‑ 0.1 ‑‑ 0.3 ‑‑ 0.1 ‑‑ 0.3 ‑‑ 0.1
Some Other Place as an Outpatient ‑‑ 0.2 ‑‑ 0.2 ‑‑ 0.2 ‑‑ 0.2 ‑‑ 0.3
Outpatient, Other Than General Medical Clinic or Doctor’s Office ‑‑ 1.4 ‑‑ 0.8 ‑‑ 1.5 ‑‑ 1.3 ‑‑ 1.5
Medications for Alcohol Use Disorder2 0.5 0.4 0.2 0.1 0.5 0.4 0.4b 0.1 0.5 0.5
Medications for Opioid Use Disorder3 0.7 0.7 0.1 0.1 0.8 0.8 0.2 0.2 0.9 0.9
Telehealth Treatment4 1.3 1.2 0.5a 0.9 1.3 1.3 1.1 1.0 1.4 1.3
Prison, Jail, or Juvenile Detention Center 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.3 0.2
OTHER SERVICES                    
Support Services                    
Support Group 2.1 2.0 0.7 0.9 2.3 2.1 1.3 1.1 2.4 2.2
Peer Support Specialist or Recovery Coach 0.8 0.8 0.2 0.3 0.8 0.8 0.5 0.5 0.9 0.9
Emergency Room/Department or Withdrawal Management Services                    
Emergency Room/Department 0.6 0.6 0.3 0.4 0.6 0.6 0.8 0.9 0.6 0.6
Withdrawal Management Services 0.3 0.4 0.1 0.1 0.4 0.4 0.3 0.2 0.4 0.5
Overdose Reversal Medicine (e.g., Narcan® or Naloxone) 0.6b 0.2 0.3a 0.2 0.6b 0.2 0.4a 0.2 0.7b 0.2

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.

NOTE: Respondents could indicate multiple types/locations for receiving substance use treatment or other services; thus, these response categories are not mutually exclusive.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.

1 Includes treatment for drug or alcohol use through support group services, peer support specialist or recovery coach services, treatment received in an emergency room/department, withdrawal management services, or overdose reversal medicine. Other services questions are asked of respondents who used drugs or alcohol in their lifetime.

2 Medications for alcohol use disorder (MAUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of alcohol.

3 Medications for opioid use disorder (MOUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of opioids. Questions for the receipt of MOUD were asked only if respondents reported lifetime use of heroin or prescription pain relievers.

4 Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.28A – Substances for Which Treatment Was Received as an Inpatient in Past Year: Among People Aged 12 or Older; by Past Year Use Disorder for Specific Substances and Age Group, Numbers in Thousands, 2024 and 2025
Substance for Which Treatment Was Received and Use Disorder for Specific Substance Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
SUBSTANCE USE DISORDER1 ‑‑ 1,738 ‑‑ 88 ‑‑ 1,650 ‑‑ 193 ‑‑ 1,457
DRUGS ‑‑ 905 ‑‑ 74 ‑‑ 832 ‑‑ 129 ‑‑ 702
Marijuana ‑‑ 235 ‑‑ 57 ‑‑ 178 ‑‑ 47 ‑‑ 132
Cocaine ‑‑ 187 ‑‑ * ‑‑ 186 ‑‑ * ‑‑ 175
Heroin ‑‑ * ‑‑ * ‑‑ * ‑‑ * ‑‑ *
Hallucinogens ‑‑ 24 ‑‑ * ‑‑ * ‑‑ * ‑‑ *
Inhalants ‑‑ * ‑‑ * ‑‑ * ‑‑ * ‑‑ *
Methamphetamine ‑‑ 181 ‑‑ * ‑‑ 181 ‑‑ * ‑‑ 154
Prescription Psychotherapeutics ‑‑ 321 ‑‑ 8 ‑‑ 312 ‑‑ 52 ‑‑ 260
Pain Relievers ‑‑ 211 ‑‑ * ‑‑ 207 ‑‑ * ‑‑ 158
Stimulants ‑‑ * ‑‑ * ‑‑ * ‑‑ 2 ‑‑ *
Tranquilizers or Sedatives ‑‑ 107 ‑‑ * ‑‑ 107 ‑‑ * ‑‑ 84
Tranquilizers ‑‑ 59 ‑‑ * ‑‑ 59 ‑‑ * ‑‑ 37
Sedatives ‑‑ * ‑‑ * ‑‑ * ‑‑ * ‑‑ *
Opioids ‑‑ 290 ‑‑ * ‑‑ 285 ‑‑ * ‑‑ 235
Central Nervous System Stimulants ‑‑ 396 ‑‑ * ‑‑ 391 ‑‑ * ‑‑ 352
ALCOHOL ‑‑ 915 ‑‑ 15 ‑‑ 899 ‑‑ 67 ‑‑ 832
BOTH DRUGS AND ALCOHOL ‑‑ 189 ‑‑ 5 ‑‑ 184 ‑‑ 18 ‑‑ 165

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Respondents with unknown information for the specific substance(s) for which they received substance use treatment were excluded from the respective analyses.

1 Includes data from respondents who were classified as having received substance use treatment but had unknown information regarding whether they received treatment specifically for drugs or alcohol.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.28B – Substances for Which Treatment Was Received as an Inpatient in Past Year: Among People Aged 12 or Older; by Past Year Use Disorder for Specific Substances and Age Group, Percentages, 2024 and 2025
Substance for Which Treatment Was Received and Use Disorder for Specific Substance Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
SUBSTANCE USE DISORDER1 ‑‑ 3.9 ‑‑ 4.7 ‑‑ 3.9 ‑‑ 2.2 ‑‑ 4.3
DRUGS ‑‑ 3.5 ‑‑ 4.9 ‑‑ 3.4 ‑‑ 2.3 ‑‑ 3.8
Marijuana ‑‑ 1.2 ‑‑ 5.1 ‑‑ 1.0 ‑‑ 0.9 ‑‑ 1.0
Cocaine ‑‑ 13.6 ‑‑ * ‑‑ 13.7 ‑‑ * ‑‑ 15.5
Heroin ‑‑ * ‑‑ * ‑‑ * ‑‑ * ‑‑ *
Hallucinogens ‑‑ 5.1 ‑‑ * ‑‑ * ‑‑ * ‑‑ *
Inhalants ‑‑ * ‑‑ * ‑‑ * ‑‑ * ‑‑ *
Methamphetamine ‑‑ 10.2 ‑‑ * ‑‑ 10.3 ‑‑ * ‑‑ 9.2
Prescription Psychotherapeutics ‑‑ 5.0 ‑‑ 2.0 ‑‑ 5.2 ‑‑ 6.8 ‑‑ 5.0
Pain Relievers ‑‑ 5.4 ‑‑ * ‑‑ 5.6 ‑‑ * ‑‑ 4.7
Stimulants ‑‑ * ‑‑ * ‑‑ * ‑‑ 0.5 ‑‑ *
Tranquilizers or Sedatives ‑‑ 6.4 ‑‑ * ‑‑ 6.6 ‑‑ * ‑‑ 6.2
Tranquilizers ‑‑ 4.3 ‑‑ * ‑‑ 4.4 ‑‑ * ‑‑ 3.2
Sedatives ‑‑ * ‑‑ * ‑‑ * ‑‑ * ‑‑ *
Opioids ‑‑ 7.4 ‑‑ * ‑‑ 7.7 ‑‑ * ‑‑ 6.9
Central Nervous System Stimulants ‑‑ 8.9 ‑‑ * ‑‑ 9.3 ‑‑ * ‑‑ 9.7
ALCOHOL ‑‑ 3.6 ‑‑ 2.2 ‑‑ 3.6 ‑‑ 1.4 ‑‑ 4.1
BOTH DRUGS AND ALCOHOL ‑‑ 2.7 ‑‑ 1.5 ‑‑ 2.7 ‑‑ 1.0 ‑‑ 3.4

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Respondents with unknown information for the specific substance(s) for which they received substance use treatment were excluded from the respective analyses.

1 Includes data from respondents who were classified as having received substance use treatment but had unknown information regarding whether they received treatment specifically for drugs or alcohol.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.29A – Substances for Which Treatment Was Received as an Outpatient in Past Year: Among People Aged 12 or Older; by Past Year Use Disorder for Specific Substances and Age Group, Numbers in Thousands, 2024 and 2025
Substance for Which Treatment Was Received and Use Disorder for Specific Substance Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
SUBSTANCE USE DISORDER1 ‑‑ 3,006 ‑‑ 131 ‑‑ 2,875 ‑‑ 426 ‑‑ 2,449
DRUGS ‑‑ 1,836 ‑‑ 114 ‑‑ 1,722 ‑‑ 313 ‑‑ 1,409
Marijuana ‑‑ 556 ‑‑ 84 ‑‑ 472 ‑‑ 207 ‑‑ 264
Cocaine ‑‑ * ‑‑ * ‑‑ * ‑‑ * ‑‑ *
Heroin ‑‑ * ‑‑ * ‑‑ * ‑‑ * ‑‑ *
Hallucinogens ‑‑ * ‑‑ * ‑‑ * ‑‑ * ‑‑ *
Inhalants ‑‑ * ‑‑ * ‑‑ * ‑‑ * ‑‑ *
Methamphetamine ‑‑ 263 ‑‑ * ‑‑ 259 ‑‑ * ‑‑ 226
Prescription Psychotherapeutics ‑‑ 586 ‑‑ 21 ‑‑ 565 ‑‑ 55 ‑‑ 510
Pain Relievers ‑‑ 382 ‑‑ * ‑‑ 375 ‑‑ * ‑‑ 339
Stimulants ‑‑ 100 ‑‑ 16 ‑‑ 84 ‑‑ 5 ‑‑ *
Tranquilizers or Sedatives ‑‑ 143 ‑‑ * ‑‑ 141 ‑‑ * ‑‑ 108
Tranquilizers ‑‑ 88 ‑‑ * ‑‑ 87 ‑‑ * ‑‑ 55
Sedatives ‑‑ * ‑‑ * ‑‑ * ‑‑ * ‑‑ *
Opioids ‑‑ 504 ‑‑ * ‑‑ 498 ‑‑ * ‑‑ 461
Central Nervous System Stimulants ‑‑ 658 ‑‑ 19 ‑‑ 639 ‑‑ * ‑‑ 586
ALCOHOL ‑‑ 1,241 ‑‑ 34 ‑‑ 1,207 ‑‑ 150 ‑‑ 1,057
BOTH DRUGS AND ALCOHOL ‑‑ 393 ‑‑ 24 ‑‑ 370 ‑‑ 60 ‑‑ 309

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Respondents with unknown information for the specific substance(s) for which they received substance use treatment were excluded from the respective analyses.

1 Includes data from respondents who were classified as having received substance use treatment but had unknown information regarding whether they received treatment specifically for drugs or alcohol.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.29B – Substances for Which Treatment Was Received as an Outpatient in Past Year: Among People Aged 12 or Older; by Past Year Use Disorder for Specific Substances and Age Group, Percentages, 2024 and 2025
Substance for Which Treatment Was Received and Use Disorder for Specific Substance Aged 12+
(2024)		 Aged 12+
(2025)		 Aged 12‑17
(2024)		 Aged 12‑17
(2025)		 Aged 18+
(2024)		 Aged 18+
(2025)		 Aged 18‑25
(2024)		 Aged 18‑25
(2025)		 Aged 26+
(2024)		 Aged 26+
(2025)
SUBSTANCE USE DISORDER1 ‑‑ 6.7 ‑‑ 7.0 ‑‑ 6.7 ‑‑ 5.0 ‑‑ 7.2
DRUGS ‑‑ 7.1 ‑‑ 7.6 ‑‑ 7.1 ‑‑ 5.5 ‑‑ 7.5
Marijuana ‑‑ 2.9 ‑‑ 7.5 ‑‑ 2.6 ‑‑ 4.1 ‑‑ 2.0
Cocaine ‑‑ * ‑‑ * ‑‑ * ‑‑ * ‑‑ *
Heroin ‑‑ * ‑‑ * ‑‑ * ‑‑ * ‑‑ *
Hallucinogens ‑‑ * ‑‑ * ‑‑ * ‑‑ * ‑‑ *
Inhalants ‑‑ * ‑‑ * ‑‑ * ‑‑ * ‑‑ *
Methamphetamine ‑‑ 14.7 ‑‑ * ‑‑ 14.5 ‑‑ * ‑‑ 13.3
Prescription Psychotherapeutics ‑‑ 9.2 ‑‑ 5.0 ‑‑ 9.5 ‑‑ 7.2 ‑‑ 9.8
Pain Relievers ‑‑ 9.8 ‑‑ * ‑‑ 10.2 ‑‑ * ‑‑ 10.2
Stimulants ‑‑ 5.8 ‑‑ 7.5 ‑‑ 5.6 ‑‑ 1.5 ‑‑ *
Tranquilizers or Sedatives ‑‑ 8.6 ‑‑ * ‑‑ 8.9 ‑‑ * ‑‑ 7.9
Tranquilizers ‑‑ 6.5 ‑‑ * ‑‑ 6.5 ‑‑ * ‑‑ 4.7
Sedatives ‑‑ * ‑‑ * ‑‑ * ‑‑ * ‑‑ *
Opioids ‑‑ 12.8 ‑‑ * ‑‑ 13.4 ‑‑ * ‑‑ 13.6
Central Nervous System Stimulants ‑‑ 14.7 ‑‑ 8.9 ‑‑ 15.0 ‑‑ * ‑‑ 16.0
ALCOHOL ‑‑ 4.8 ‑‑ 4.8 ‑‑ 4.8 ‑‑ 3.2 ‑‑ 5.2
BOTH DRUGS AND ALCOHOL ‑‑ 5.5 ‑‑ 6.9 ‑‑ 5.5 ‑‑ 3.2 ‑‑ 6.3

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

NOTE: Respondents with unknown information for the specific substance(s) for which they received substance use treatment were excluded from the respective analyses.

1 Includes data from respondents who were classified as having received substance use treatment but had unknown information regarding whether they received treatment specifically for drugs or alcohol.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.30A – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Age Group and Past Year Substance Use Disorder, Numbers in Thousands, 2024 and 2025
Substance Use Disorder/Age Group Treatment for Drugs1
(2024)		 Treatment for Drugs1
(2025)		 Treatment for Alcohol1
(2024)		 Treatment for Alcohol1
(2025)		 Treatment for Both Drugs and Alcohol1
(2024)		 Treatment for Both Drugs and Alcohol1
(2025)		 Treatment for Substance Use2
(2024)		 Treatment for Substance Use2
(2025)
DRUGS ‑‑ 3,000 ‑‑ 1,691 ‑‑ 1,071 ‑‑ 3,711
12‑17 ‑‑ 243 ‑‑ 113 ‑‑ 85 ‑‑ 274
18 or Older ‑‑ 2,757 ‑‑ 1,579 ‑‑ 985 ‑‑ 3,436
18‑25 ‑‑ 432 ‑‑ 214 ‑‑ 135 ‑‑ 526
26 or Older ‑‑ 2,325 ‑‑ 1,364 ‑‑ 850 ‑‑ 2,910
ALCOHOL ‑‑ 1,268 ‑‑ 2,253 ‑‑ 838 ‑‑ 2,778
12‑17 ‑‑ 69 ‑‑ 77 ‑‑ 52 ‑‑ 94
18 or Older ‑‑ 1,199 ‑‑ 2,176 ‑‑ 785 ‑‑ 2,684
18‑25 ‑‑ 197 ‑‑ 274 ‑‑ 114 ‑‑ 369
26 or Older ‑‑ 1,002 ‑‑ 1,902 ‑‑ 671 ‑‑ 2,315
BOTH DRUGS AND ALCOHOL ‑‑ 1,006 ‑‑ 1,219 ‑‑ 704 ‑‑ 1,591
12‑17 ‑‑ 59 ‑‑ 71 ‑‑ 49 ‑‑ 82
18 or Older ‑‑ 946 ‑‑ 1,148 ‑‑ 655 ‑‑ 1,509
18‑25 ‑‑ 178 ‑‑ 172 ‑‑ 105 ‑‑ 255
26 or Older ‑‑ 768 ‑‑ 976 ‑‑ 550 ‑‑ 1,254
SUBSTANCE USE DISORDER ‑‑ 3,262 ‑‑ 2,725 ‑‑ 1,204 ‑‑ 4,898
12‑17 ‑‑ 252 ‑‑ 118 ‑‑ 88 ‑‑ 286
18 or Older ‑‑ 3,009 ‑‑ 2,607 ‑‑ 1,116 ‑‑ 4,612
18‑25 ‑‑ 451 ‑‑ 317 ‑‑ 145 ‑‑ 640
26 or Older ‑‑ 2,558 ‑‑ 2,290 ‑‑ 971 ‑‑ 3,972

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown information for the specific substance(s) for which they received substance use treatment were excluded from the respective analyses.

2 Includes data from respondents who were classified as having received substance use treatment but had unknown information regarding whether they received treatment specifically for drugs or alcohol.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.30B – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Age Group and Past Year Substance Use Disorder, Percentages, 2024 and 2025
Substance Use Disorder/Age Group Treatment for Drugs1
(2024)		 Treatment for Drugs1
(2025)		 Treatment for Alcohol1
(2024)		 Treatment for Alcohol1
(2025)		 Treatment for Both Drugs and Alcohol1
(2024)		 Treatment for Both Drugs and Alcohol1
(2025)		 Treatment for Substance Use2
(2024)		 Treatment for Substance Use2
(2025)
DRUGS ‑‑ 11.6 ‑‑ 6.5 ‑‑ 4.1 ‑‑ 14.3
12‑17 ‑‑ 16.1 ‑‑ 7.5 ‑‑ 5.7 ‑‑ 18.2
18 or Older ‑‑ 11.3 ‑‑ 6.5 ‑‑ 4.0 ‑‑ 14.0
18‑25 ‑‑ 7.6 ‑‑ 3.8 ‑‑ 2.4 ‑‑ 9.2
26 or Older ‑‑ 12.5 ‑‑ 7.3 ‑‑ 4.6 ‑‑ 15.5
ALCOHOL ‑‑ 4.9 ‑‑ 8.8 ‑‑ 3.3 ‑‑ 10.8
12‑17 ‑‑ 9.7 ‑‑ 10.8 ‑‑ 7.4 ‑‑ 13.2
18 or Older ‑‑ 4.8 ‑‑ 8.7 ‑‑ 3.2 ‑‑ 10.7
18‑25 ‑‑ 4.2 ‑‑ 5.8 ‑‑ 2.4 ‑‑ 7.8
26 or Older ‑‑ 5.0 ‑‑ 9.4 ‑‑ 3.3 ‑‑ 11.4
BOTH DRUGS AND ALCOHOL ‑‑ 14.2 ‑‑ 17.3 ‑‑ 10.0 ‑‑ 22.3
12‑17 ‑‑ 17.3 ‑‑ 20.8 ‑‑ 14.2 ‑‑ 23.8
18 or Older ‑‑ 14.1 ‑‑ 17.1 ‑‑ 9.7 ‑‑ 22.2
18‑25 ‑‑ 9.6 ‑‑ 9.2 ‑‑ 5.6 ‑‑ 13.6
26 or Older ‑‑ 15.8 ‑‑ 20.1 ‑‑ 11.3 ‑‑ 25.5
SUBSTANCE USE DISORDER ‑‑ 7.3 ‑‑ 6.1 ‑‑ 2.7 ‑‑ 11.0
12‑17 ‑‑ 13.5 ‑‑ 6.3 ‑‑ 4.7 ‑‑ 15.3
18 or Older ‑‑ 7.1 ‑‑ 6.1 ‑‑ 2.6 ‑‑ 10.8
18‑25 ‑‑ 5.3 ‑‑ 3.7 ‑‑ 1.7 ‑‑ 7.5
26 or Older ‑‑ 7.5 ‑‑ 6.7 ‑‑ 2.9 ‑‑ 11.6

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Respondents with unknown information for the specific substance(s) for which they received substance use treatment were excluded from the respective analyses.

2 Includes data from respondents who were classified as having received substance use treatment but had unknown information regarding whether they received treatment specifically for drugs or alcohol.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.31A – Receipt of Substance Use Treatment and Receipt of Substance Use Treatment or Other Services in Past Year: Among People Aged 12 or Older with Substance Use Disorder in Past Year; by Substance Use Disorder Severity Level and Age Group, Numbers in Thousands, 2024 and 2025
Substance Use Disorder Severity Level/Age Group Among People Aged 12 or Older with Substance Use Disorder in Past Year
Received Substance Use Treatment (SU Tx)
(2024)		 Received Substance Use Treatment (SU Tx)
(2025)		 Did Not Receive SU Tx
(2024)		 Did Not Receive SU Tx
(2025)		 Received SU Tx or Other Services1
(2024)		 Received SU Tx or Other Services1
(2025)		 Did Not Receive SU Tx or Other Services1
(2024)		 Did Not Receive SU Tx or Other Services1
(2025)
Any SUD ‑‑ 4,898 ‑‑ 39,677 ‑‑ 6,070 ‑‑ 38,506
12‑17 ‑‑ 286 ‑‑ 1,591 ‑‑ 366 ‑‑ 1,511
18 or Older ‑‑ 4,612 ‑‑ 38,087 ‑‑ 5,704 ‑‑ 36,995
18‑25 ‑‑ 640 ‑‑ 7,937 ‑‑ 809 ‑‑ 7,768
26 or Older ‑‑ 3,972 ‑‑ 30,150 ‑‑ 4,894 ‑‑ 29,227
Mild SUD ‑‑ 980 ‑‑ 23,122 ‑‑ 1,316 ‑‑ 22,786
12‑17 ‑‑ 75 ‑‑ 853 ‑‑ 102 ‑‑ 826
18 or Older ‑‑ 905 ‑‑ 22,269 ‑‑ 1,215 ‑‑ 21,960
18‑25 ‑‑ 115 ‑‑ 4,090 ‑‑ 167 ‑‑ 4,039
26 or Older ‑‑ 790 ‑‑ 18,179 ‑‑ 1,048 ‑‑ 17,921
Moderate SUD ‑‑ 1,017 ‑‑ 9,426 ‑‑ 1,404 ‑‑ 9,039
12‑17 ‑‑ 78 ‑‑ 401 ‑‑ 104 ‑‑ 374
18 or Older ‑‑ 939 ‑‑ 9,025 ‑‑ 1,300 ‑‑ 8,665
18‑25 ‑‑ 117 ‑‑ 2,189 ‑‑ 154 ‑‑ 2,151
26 or Older ‑‑ 823 ‑‑ 6,837 ‑‑ 1,146 ‑‑ 6,514
Severe SUD ‑‑ 2,901 ‑‑ 7,129 ‑‑ 3,349 ‑‑ 6,681
12‑17 ‑‑ 134 ‑‑ 336 ‑‑ 160 ‑‑ 311
18 or Older ‑‑ 2,767 ‑‑ 6,793 ‑‑ 3,189 ‑‑ 6,370
18‑25 ‑‑ 408 ‑‑ 1,659 ‑‑ 489 ‑‑ 1,578
26 or Older ‑‑ 2,359 ‑‑ 5,134 ‑‑ 2,700 ‑‑ 4,792

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes treatment for drug or alcohol use through support group services, peer support specialist or recovery coach services, treatment received in an emergency room/department, withdrawal management services, or overdose reversal medicine. Other services questions are asked of respondents who used drugs or alcohol in their lifetime.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.31B – Receipt of Substance Use Treatment and Receipt of Substance Use Treatment or Other Services in Past Year: Among People Aged 12 or Older with Substance Use Disorder in Past Year; by Substance Use Disorder Severity Level and Age Group, Percentages, 2024 and 2025
Substance Use Disorder Severity Level/Age Group Among People Aged 12 or Older with Substance Use Disorder in Past Year
Received Substance Use Treatment (SU Tx)
(2024)		 Received Substance Use Treatment (SU Tx)
(2025)		 Did Not Receive SU Tx
(2024)		 Did Not Receive SU Tx
(2025)		 Received SU Tx or Other Services1
(2024)		 Received SU Tx or Other Services1
(2025)		 Did Not Receive SU Tx or Other Services1
(2024)		 Did Not Receive SU Tx or Other Services1
(2025)
Any SUD ‑‑ 11.0 ‑‑ 89.0 ‑‑ 13.6 ‑‑ 86.4
12‑17 ‑‑ 15.3 ‑‑ 84.7 ‑‑ 19.5 ‑‑ 80.5
18 or Older ‑‑ 10.8 ‑‑ 89.2 ‑‑ 13.4 ‑‑ 86.6
18‑25 ‑‑ 7.5 ‑‑ 92.5 ‑‑ 9.4 ‑‑ 90.6
26 or Older ‑‑ 11.6 ‑‑ 88.4 ‑‑ 14.3 ‑‑ 85.7
Mild SUD ‑‑ 4.1 ‑‑ 95.9 ‑‑ 5.5 ‑‑ 94.5
12‑17 ‑‑ 8.1 ‑‑ 91.9 ‑‑ 11.0 ‑‑ 89.0
18 or Older ‑‑ 3.9 ‑‑ 96.1 ‑‑ 5.2 ‑‑ 94.8
18‑25 ‑‑ 2.7 ‑‑ 97.3 ‑‑ 4.0 ‑‑ 96.0
26 or Older ‑‑ 4.2 ‑‑ 95.8 ‑‑ 5.5 ‑‑ 94.5
Moderate SUD ‑‑ 9.7 ‑‑ 90.3 ‑‑ 13.4 ‑‑ 86.6
12‑17 ‑‑ 16.2 ‑‑ 83.8 ‑‑ 21.8 ‑‑ 78.2
18 or Older ‑‑ 9.4 ‑‑ 90.6 ‑‑ 13.0 ‑‑ 87.0
18‑25 ‑‑ 5.1 ‑‑ 94.9 ‑‑ 6.7 ‑‑ 93.3
26 or Older ‑‑ 10.7 ‑‑ 89.3 ‑‑ 15.0 ‑‑ 85.0
Severe SUD ‑‑ 28.9 ‑‑ 71.1 ‑‑ 33.4 ‑‑ 66.6
12‑17 ‑‑ 28.5 ‑‑ 71.5 ‑‑ 34.0 ‑‑ 66.0
18 or Older ‑‑ 28.9 ‑‑ 71.1 ‑‑ 33.4 ‑‑ 66.6
18‑25 ‑‑ 19.8 ‑‑ 80.2 ‑‑ 23.7 ‑‑ 76.3
26 or Older ‑‑ 31.5 ‑‑ 68.5 ‑‑ 36.0 ‑‑ 64.0

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes treatment for drug or alcohol use through support group services, peer support specialist or recovery coach services, treatment received in an emergency room/department, withdrawal management services, or overdose reversal medicine. Other services questions are asked of respondents who used drugs or alcohol in their lifetime.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.32A – Classified as Needing Substance Use Treatment: Among People Aged 12 or Older; Receipt of Substance Use Treatment and Receipt of Substance Use Treatment or Other Services in Past Year: Among People Aged 12 or Older Classified as Needing Substance Use Treatment in Past Year; by Demographic Characteristics, Numbers in Thousands and Percentages, 2024 and 2025
Demographic Characteristic Among the Total Population Among People Classified as Needing Substance Use Treatment (SU Tx)
Classified as Needing SU Tx
(2024)		 Classified as Needing SU Tx
(2025)		 % Who Received SU Tx
(2024)		 % Who Received SU Tx
(2025)		 % Who Did Not Receive SU Tx
(2024)		 % Who Did Not Receive SU Tx
(2025)		 % Who Received SU Tx or Other Services1
(2024)		 % Who Received SU Tx or Other Services1
(2025)		 % Who Did Not Receive SU Tx or Other Services1
(2024)		 % Who Did Not Receive SU Tx or Other Services1
(2025)
TOTAL ‑‑ 47,231 ‑‑ 16.0 ‑‑ 84.0 ‑‑ 18.5 ‑‑ 81.5
AGE GROUP                    
12‑17 ‑‑ 2,061 ‑‑ 22.8 ‑‑ 77.2 ‑‑ 26.7 ‑‑ 73.3
18 or Older ‑‑ 45,170 ‑‑ 15.7 ‑‑ 84.3 ‑‑ 18.1 ‑‑ 81.9
18‑25 ‑‑ 8,782 ‑‑ 9.6 ‑‑ 90.4 ‑‑ 11.6 ‑‑ 88.4
26 or Older ‑‑ 36,388 ‑‑ 17.1 ‑‑ 82.9 ‑‑ 19.7 ‑‑ 80.3
SEX                    
Male ‑‑ 26,848 ‑‑ 15.3 ‑‑ 84.7 ‑‑ 18.1 ‑‑ 81.9
Female ‑‑ 20,383 ‑‑ 16.9 ‑‑ 83.1 ‑‑ 18.9 ‑‑ 81.1
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino ‑‑ 38,087 ‑‑ 16.5 ‑‑ 83.5 ‑‑ 18.7 ‑‑ 81.3
AIAN ‑‑ 385 ‑‑ 25.4 ‑‑ 74.6 ‑‑ 31.5 ‑‑ 68.5
Asian ‑‑ 1,402 ‑‑ 9.4 ‑‑ 90.6 ‑‑ 11.4 ‑‑ 88.6
Black or African American ‑‑ 5,946 ‑‑ 14.1 ‑‑ 85.9 ‑‑ 16.7 ‑‑ 83.3
NHPI ‑‑ 184 ‑‑ * ‑‑ * ‑‑ * ‑‑ *
White ‑‑ 28,071 ‑‑ 17.1 ‑‑ 82.9 ‑‑ 19.2 ‑‑ 80.8
Two or More Races ‑‑ 2,100 ‑‑ 18.7 ‑‑ 81.3 ‑‑ 21.9 ‑‑ 78.1
Hispanic or Latino ‑‑ 9,144 ‑‑ 14.1 ‑‑ 85.9 ‑‑ 17.4 ‑‑ 82.6

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Respondents were classified as needing substance use treatment if they met DSM‑5 criteria for a drug or alcohol use disorder or received treatment for drug or alcohol use.

NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes treatment for drug or alcohol use through support group services, peer support specialist or recovery coach services, treatment received in an emergency room/department, withdrawal management services, or overdose reversal medicine. Other services questions are asked of respondents who used drugs or alcohol in their lifetime.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.32B – Classified as Needing Substance Use Treatment: Among People Aged 12 or Older; Receipt of Substance Use Treatment and Receipt of Substance Use Treatment or Other Services in Past Year: Among People Aged 12 or Older Classified as Needing Substance Use Treatment in Past Year; by Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Among the Total Population Among People Classified as Needing Substance Use Treatment (SU Tx)
Classified as Needing SU Tx
(2024)		 Classified as Needing SU Tx
(2025)		 % Who Received SU Tx
(2024)		 % Who Received SU Tx
(2025)		 % Who Did Not Receive SU Tx
(2024)		 % Who Did Not Receive SU Tx
(2025)		 % Who Received SU Tx or Other Services1
(2024)		 % Who Received SU Tx or Other Services1
(2025)		 % Who Did Not Receive SU Tx or Other Services1
(2024)		 % Who Did Not Receive SU Tx or Other Services1
(2025)
TOTAL ‑‑ 16.3 ‑‑ 16.0 ‑‑ 84.0 ‑‑ 18.5 ‑‑ 81.5
AGE GROUP                    
12‑17 ‑‑ 8.1 ‑‑ 22.8 ‑‑ 77.2 ‑‑ 26.7 ‑‑ 73.3
18 or Older ‑‑ 17.0 ‑‑ 15.7 ‑‑ 84.3 ‑‑ 18.1 ‑‑ 81.9
18‑25 ‑‑ 24.3 ‑‑ 9.6 ‑‑ 90.4 ‑‑ 11.6 ‑‑ 88.4
26 or Older ‑‑ 15.9 ‑‑ 17.1 ‑‑ 82.9 ‑‑ 19.7 ‑‑ 80.3
SEX                    
Male ‑‑ 19.1 ‑‑ 15.3 ‑‑ 84.7 ‑‑ 18.1 ‑‑ 81.9
Female ‑‑ 13.6 ‑‑ 16.9 ‑‑ 83.1 ‑‑ 18.9 ‑‑ 81.1
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino ‑‑ 16.3 ‑‑ 16.5 ‑‑ 83.5 ‑‑ 18.7 ‑‑ 81.3
AIAN ‑‑ 20.8 ‑‑ 25.4 ‑‑ 74.6 ‑‑ 31.5 ‑‑ 68.5
Asian ‑‑ 7.3 ‑‑ 9.4 ‑‑ 90.6 ‑‑ 11.4 ‑‑ 88.6
Black or African American ‑‑ 17.2 ‑‑ 14.1 ‑‑ 85.9 ‑‑ 16.7 ‑‑ 83.3
NHPI ‑‑ 17.3 ‑‑ * ‑‑ * ‑‑ * ‑‑ *
White ‑‑ 16.7 ‑‑ 17.1 ‑‑ 82.9 ‑‑ 19.2 ‑‑ 80.8
Two or More Races ‑‑ 22.2 ‑‑ 18.7 ‑‑ 81.3 ‑‑ 21.9 ‑‑ 78.1
Hispanic or Latino ‑‑ 16.2 ‑‑ 14.1 ‑‑ 85.9 ‑‑ 17.4 ‑‑ 82.6

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Respondents were classified as needing substance use treatment if they met DSM‑5 criteria for a drug or alcohol use disorder or received treatment for drug or alcohol use.

NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

1 Includes treatment for drug or alcohol use through support group services, peer support specialist or recovery coach services, treatment received in an emergency room/department, withdrawal management services, or overdose reversal medicine. Other services questions are asked of respondents who used drugs or alcohol in their lifetime.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.33A – Classified as Needing Alcohol Use Treatment: Among People Aged 12 or Older; Receipt of Alcohol Use Treatment in Past Year: Among People Aged 12 or Older Classified as Needing Alcohol Use Treatment in Past Year; by Demographic Characteristics, Numbers in Thousands and Percentages, 2024 and 2025
Demographic Characteristic Among the Total Population Among People Classified as Needing Alcohol Use Treatment (ALC Tx)
Classified as Needing ALC Tx
(2024)		 Classified as Needing ALC Tx
(2025)		 % Who Received ALC Tx
(2024)		 % Who Received ALC Tx
(2025)		 % Who Did Not Receive ALC Tx
(2024)		 % Who Did Not Receive ALC Tx
(2025)
TOTAL ‑‑ 27,260 ‑‑ 13.9 ‑‑ 86.1
AGE GROUP            
12‑17 ‑‑ 798 ‑‑ 20.7 ‑‑ 79.3
18 or Older ‑‑ 26,461 ‑‑ 13.7 ‑‑ 86.3
18‑25 ‑‑ 4,891 ‑‑ 8.9 ‑‑ 91.1
26 or Older ‑‑ 21,570 ‑‑ 14.8 ‑‑ 85.2
SEX            
Male ‑‑ 16,342 ‑‑ 14.0 ‑‑ 86.0
Female ‑‑ 10,917 ‑‑ 13.7 ‑‑ 86.3
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino ‑‑ 21,588 ‑‑ 14.0 ‑‑ 86.0
AIAN ‑‑ 174 ‑‑ * ‑‑ *
Asian ‑‑ 918 ‑‑ 2.5 ‑‑ 97.5
Black or African American ‑‑ 3,181 ‑‑ 16.8 ‑‑ 83.2
NHPI ‑‑ 81 ‑‑ * ‑‑ *
White ‑‑ 16,191 ‑‑ 13.6 ‑‑ 86.4
Two or More Races ‑‑ 1,043 ‑‑ * ‑‑ *
Hispanic or Latino ‑‑ 5,672 ‑‑ 13.6 ‑‑ 86.4

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Respondents were classified as needing alcohol use treatment if they met DSM‑5 criteria for an alcohol use disorder or received treatment for alcohol use.

NOTE: Alcohol use treatment includes treatment for alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Alcohol use treatment questions are asked of respondents who used alcohol in their lifetime. Respondents with unknown information for the receipt of substance use treatment specifically for alcohol use were excluded.

NOTE: Alcohol use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.33B – Classified as Needing Alcohol Use Treatment: Among People Aged 12 or Older; Receipt of Alcohol Use Treatment in Past Year: Among People Aged 12 or Older Classified as Needing Alcohol Use Treatment in Past Year; by Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Among the Total Population Among People Classified as Needing Alcohol Use Treatment (ALC Tx)
Classified as Needing ALC Tx
(2024)		 Classified as Needing ALC Tx
(2025)		 % Who Received ALC Tx
(2024)		 % Who Received ALC Tx
(2025)		 % Who Did Not Receive ALC Tx
(2024)		 % Who Did Not Receive ALC Tx
(2025)
TOTAL ‑‑ 9.4 ‑‑ 13.9 ‑‑ 86.1
AGE GROUP            
12‑17 ‑‑ 3.1 ‑‑ 20.7 ‑‑ 79.3
18 or Older ‑‑ 10.0 ‑‑ 13.7 ‑‑ 86.3
18‑25 ‑‑ 13.6 ‑‑ 8.9 ‑‑ 91.1
26 or Older ‑‑ 9.4 ‑‑ 14.8 ‑‑ 85.2
SEX            
Male ‑‑ 11.6 ‑‑ 14.0 ‑‑ 86.0
Female ‑‑ 7.3 ‑‑ 13.7 ‑‑ 86.3
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino ‑‑ 9.2 ‑‑ 14.0 ‑‑ 86.0
AIAN ‑‑ 9.4 ‑‑ * ‑‑ *
Asian ‑‑ 4.8 ‑‑ 2.5 ‑‑ 97.5
Black or African American ‑‑ 9.2 ‑‑ 16.8 ‑‑ 83.2
NHPI ‑‑ 7.6 ‑‑ * ‑‑ *
White ‑‑ 9.6 ‑‑ 13.6 ‑‑ 86.4
Two or More Races ‑‑ 11.0 ‑‑ * ‑‑ *
Hispanic or Latino ‑‑ 10.0 ‑‑ 13.6 ‑‑ 86.4

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Respondents were classified as needing alcohol use treatment if they met DSM‑5 criteria for an alcohol use disorder or received treatment for alcohol use.

NOTE: Alcohol use treatment includes treatment for alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Alcohol use treatment questions are asked of respondents who used alcohol in their lifetime. Respondents with unknown information for the receipt of substance use treatment specifically for alcohol use were excluded.

NOTE: Alcohol use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.34A – Perceived Unmet Need for Substance Use Treatment in Past Year: Among People Aged 12 to 17 with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year; by Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Among People Aged 12 to 17 with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year
Any Perceived Unmet Need
(2024)		 Any Perceived Unmet Need
(2025)		 Sought Treatment
(2024)		 Sought Treatment
(2025)		 Did Not Seek Treatment but Thought Should Get Treatment
(2024)		 Did Not Seek Treatment but Thought Should Get Treatment
(2025)		 Did Not Perceive Need for Substance Use Treatment
(2024)		 Did Not Perceive Need for Substance Use Treatment
(2025)
TOTAL ‑‑ 74 ‑‑ 11 ‑‑ 63 ‑‑ 1,446
AGE GROUP                
12‑13 ‑‑ 15 ‑‑ * ‑‑ 11 ‑‑ 166
14‑15 ‑‑ 31 ‑‑ 4 ‑‑ 27 ‑‑ 443
16‑17 ‑‑ 29 ‑‑ 3 ‑‑ 25 ‑‑ 838
SEX                
Male ‑‑ 39 ‑‑ 3 ‑‑ 36 ‑‑ 667
Female ‑‑ 35 ‑‑ 8 ‑‑ 27 ‑‑ 779
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino ‑‑ 47 ‑‑ 8 ‑‑ 39 ‑‑ 1,003
AIAN ‑‑ * ‑‑ * ‑‑ * ‑‑ *
Asian ‑‑ * ‑‑ * ‑‑ * ‑‑ *
Black or African American ‑‑ 7 ‑‑ * ‑‑ 6 ‑‑ 240
NHPI ‑‑ * ‑‑ * ‑‑ * ‑‑ *
White ‑‑ 32 ‑‑ * ‑‑ 29 ‑‑ 619
Two or More Races ‑‑ 4 ‑‑ * ‑‑ 3 ‑‑ 99
Hispanic or Latino ‑‑ 28 ‑‑ 3 ‑‑ * ‑‑ 444

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Respondents were classified as having a perceived unmet need for substance use treatment (SU Tx) if they did not receive SU Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for SU Tx were excluded.

NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.34B – Perceived Unmet Need for Substance Use Treatment in Past Year: Among People Aged 12 to 17 with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year; by Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Among People Aged 12 to 17 with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year
Any Perceived Unmet Need
(2024)		 Any Perceived Unmet Need
(2025)		 Sought Treatment
(2024)		 Sought Treatment
(2025)		 Did Not Seek Treatment but Thought Should Get Treatment
(2024)		 Did Not Seek Treatment but Thought Should Get Treatment
(2025)		 Did Not Perceive Need for Substance Use Treatment
(2024)		 Did Not Perceive Need for Substance Use Treatment
(2025)
TOTAL ‑‑ 4.9 ‑‑ 0.7 ‑‑ 4.2 ‑‑ 95.1
AGE GROUP                
12‑13 ‑‑ 8.2 ‑‑ * ‑‑ 6.2 ‑‑ 91.8
14‑15 ‑‑ 6.5 ‑‑ 0.8 ‑‑ 5.7 ‑‑ 93.5
16‑17 ‑‑ 3.3 ‑‑ 0.4 ‑‑ 2.9 ‑‑ 96.7
SEX                
Male ‑‑ 5.5 ‑‑ 0.4 ‑‑ 5.1 ‑‑ 94.5
Female ‑‑ 4.3 ‑‑ 1.0 ‑‑ 3.4 ‑‑ 95.7
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino ‑‑ 4.4 ‑‑ 0.7 ‑‑ 3.7 ‑‑ 95.6
AIAN ‑‑ * ‑‑ * ‑‑ * ‑‑ *
Asian ‑‑ * ‑‑ * ‑‑ * ‑‑ *
Black or African American ‑‑ 3.0 ‑‑ * ‑‑ 2.3 ‑‑ 97.0
NHPI ‑‑ * ‑‑ * ‑‑ * ‑‑ *
White ‑‑ 5.0 ‑‑ * ‑‑ 4.4 ‑‑ 95.0
Two or More Races ‑‑ 3.8 ‑‑ * ‑‑ 2.7 ‑‑ 96.2
Hispanic or Latino ‑‑ 5.9 ‑‑ 0.7 ‑‑ * ‑‑ 94.1

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Respondents were classified as having a perceived unmet need for substance use treatment (SU Tx) if they did not receive SU Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for SU Tx were excluded.

NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.35A – Perceived Unmet Need for Substance Use Treatment in Past Year: Among People Aged 18 or Older with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year; by Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic Among People Aged 18 or Older with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year
Any Perceived Unmet Need
(2024)		 Any Perceived Unmet Need
(2025)		 Sought Treatment
(2024)		 Sought Treatment
(2025)		 Did Not Seek Treatment but Thought Should Get Treatment
(2024)		 Did Not Seek Treatment but Thought Should Get Treatment
(2025)		 Did Not Perceive Need for Substance Use Treatment
(2024)		 Did Not Perceive Need for Substance Use Treatment
(2025)
TOTAL ‑‑ 2,038 ‑‑ 187 ‑‑ 1,851 ‑‑ 34,911
AGE GROUP                
18‑25 ‑‑ 323 ‑‑ 29 ‑‑ 295 ‑‑ 7,459
26 or Older ‑‑ 1,715 ‑‑ 158 ‑‑ 1,557 ‑‑ 27,452
26‑49 ‑‑ 1,167 ‑‑ 121 ‑‑ 1,046 ‑‑ 17,164
50 or Older ‑‑ 547 ‑‑ 37 ‑‑ 510 ‑‑ 10,288
SEX                
Male ‑‑ 1,214 ‑‑ 127 ‑‑ 1,087 ‑‑ 20,110
Female ‑‑ 823 ‑‑ 59 ‑‑ 764 ‑‑ 14,801
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino ‑‑ 1,605 ‑‑ 172 ‑‑ 1,432 ‑‑ 28,283
AIAN ‑‑ 2 ‑‑ * ‑‑ 2 ‑‑ 200
Asian ‑‑ * ‑‑ * ‑‑ * ‑‑ *
Black or African American ‑‑ 224 ‑‑ 34 ‑‑ 190 ‑‑ 4,419
NHPI ‑‑ * ‑‑ * ‑‑ * ‑‑ *
White ‑‑ 1,290 ‑‑ 137 ‑‑ 1,153 ‑‑ 20,835
Two or More Races ‑‑ 45 ‑‑ 2 ‑‑ 43 ‑‑ 1,515
Hispanic or Latino ‑‑ 433 ‑‑ 14 ‑‑ 419 ‑‑ 6,629

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Respondents were classified as having a perceived unmet need for substance use treatment (SU Tx) if they did not receive SU Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for SU Tx were excluded.

NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.35B – Perceived Unmet Need for Substance Use Treatment in Past Year: Among People Aged 18 or Older with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year; by Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic Among People Aged 18 or Older with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year
Any Perceived Unmet Need
(2024)		 Any Perceived Unmet Need
(2025)		 Sought Treatment
(2024)		 Sought Treatment
(2025)		 Did Not Seek Treatment but Thought Should Get Treatment
(2024)		 Did Not Seek Treatment but Thought Should Get Treatment
(2025)		 Did Not Perceive Need for Substance Use Treatment
(2024)		 Did Not Perceive Need for Substance Use Treatment
(2025)
TOTAL ‑‑ 5.5 ‑‑ 0.5 ‑‑ 5.0 ‑‑ 94.5
AGE GROUP                
18‑25 ‑‑ 4.2 ‑‑ 0.4 ‑‑ 3.8 ‑‑ 95.8
26 or Older ‑‑ 5.9 ‑‑ 0.5 ‑‑ 5.3 ‑‑ 94.1
26‑49 ‑‑ 6.4 ‑‑ 0.7 ‑‑ 5.7 ‑‑ 93.6
50 or Older ‑‑ 5.1 ‑‑ 0.3 ‑‑ 4.7 ‑‑ 94.9
SEX                
Male ‑‑ 5.7 ‑‑ 0.6 ‑‑ 5.1 ‑‑ 94.3
Female ‑‑ 5.3 ‑‑ 0.4 ‑‑ 4.9 ‑‑ 94.7
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino ‑‑ 5.4 ‑‑ 0.6 ‑‑ 4.8 ‑‑ 94.6
AIAN ‑‑ 0.9 ‑‑ * ‑‑ 0.9 ‑‑ 99.1
Asian ‑‑ * ‑‑ * ‑‑ * ‑‑ *
Black or African American ‑‑ 4.8 ‑‑ 0.7 ‑‑ 4.1 ‑‑ 95.2
NHPI ‑‑ * ‑‑ * ‑‑ * ‑‑ *
White ‑‑ 5.8 ‑‑ 0.6 ‑‑ 5.2 ‑‑ 94.2
Two or More Races ‑‑ 2.9 ‑‑ 0.1 ‑‑ 2.8 ‑‑ 97.1
Hispanic or Latino ‑‑ 6.1 ‑‑ 0.2 ‑‑ 5.9 ‑‑ 93.9

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Respondents were classified as having a perceived unmet need for substance use treatment (SU Tx) if they did not receive SU Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for SU Tx were excluded.

NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.

NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.36A – Detailed Reasons for Not Receiving Substance Use Treatment in Past Year: Among People Aged 12 to 17 Who Did Not Receive Substance Use Treatment and Had a Perceived Unmet Need for Substance Use Treatment in Past Year; Numbers in Thousands, 2024 and 2025
Reason for Not Receiving Substance Use Treatment Total
(2024)		 Total
(2025)
Thought It Would Cost Too Much ‑‑ *
Did Not Have Health Insurance Coverage for Drug or Alcohol Use Treatment ‑‑ 5
Health Insurance Would Not Pay Enough of Costs for Treatment ‑‑ *
Did Not Know How or Where to Get Treatment ‑‑ *
Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to ‑‑ *
No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to ‑‑ 1
Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times that Worked for Them ‑‑ *
Did Not Have Enough Time for Treatment ‑‑ *
Worried That Information Would Not Be Kept Private ‑‑ *
Worried about What People Would Think or Say if They Got Treatment ‑‑ *
Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children ‑‑ *
Not Ready to Start Treatment ‑‑ *
Not Ready to Stop or Cut Back Using Drugs or Alcohol ‑‑ *
Thought They Should Have Been Able to Handle Their Drug or Alcohol Use on Their Own ‑‑ *
Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment ‑‑ *
Thought They Would Be Forced to Stay in Rehab or Treatment against Their Will ‑‑ *
Did Not Think Treatment Would Help Them ‑‑ *
Thought No One Would Care if They Got Better ‑‑ *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.

NOTE: Respondents could indicate multiple reasons for not receiving substance use treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reasons for not receiving substance use treatment data were excluded.

NOTE: Respondents were classified as having a perceived unmet need for substance use treatment (SU Tx) if they did not receive SU Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for SU Tx were excluded.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.36B – Detailed Reasons for Not Receiving Substance Use Treatment in Past Year: Among People Aged 12 to 17 Who Did Not Receive Substance Use Treatment and Had a Perceived Unmet Need for Substance Use Treatment in Past Year; Percentages, 2024 and 2025
Reason for Not Receiving Substance Use Treatment Total
(2024)		 Total
(2025)
Thought It Would Cost Too Much ‑‑ *
Did Not Have Health Insurance Coverage for Drug or Alcohol Use Treatment ‑‑ 4.0
Health Insurance Would Not Pay Enough of Costs for Treatment ‑‑ *
Did Not Know How or Where to Get Treatment ‑‑ *
Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to ‑‑ *
No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to ‑‑ 1.1
Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times that Worked for Them ‑‑ *
Did Not Have Enough Time for Treatment ‑‑ *
Worried That Information Would Not Be Kept Private ‑‑ *
Worried about What People Would Think or Say if They Got Treatment ‑‑ *
Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children ‑‑ *
Not Ready to Start Treatment ‑‑ *
Not Ready to Stop or Cut Back Using Drugs or Alcohol ‑‑ *
Thought They Should Have Been Able to Handle Their Drug or Alcohol Use on Their Own ‑‑ *
Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment ‑‑ *
Thought They Would Be Forced to Stay in Rehab or Treatment against Their Will ‑‑ *
Did Not Think Treatment Would Help Them ‑‑ *
Thought No One Would Care if They Got Better ‑‑ *

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.

NOTE: Respondents could indicate multiple reasons for not receiving substance use treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reasons for not receiving substance use treatment data were excluded.

NOTE: Respondents were classified as having a perceived unmet need for substance use treatment (SU Tx) if they did not receive SU Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for SU Tx were excluded.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.37A – Detailed Reasons for Not Receiving Substance Use Treatment in Past Year: Among People Aged 18 or Older Who Did Not Receive Substance Use Treatment and Had a Perceived Unmet Need for Substance Use Treatment in Past Year; Numbers in Thousands, 2024 and 2025
Reason for Not Receiving Substance Use Treatment Total
(2024)		 Total
(2025)
Thought It Would Cost Too Much ‑‑ 876
Did Not Have Health Insurance Coverage for Drug or Alcohol Use Treatment ‑‑ 598
Health Insurance Would Not Pay Enough of Costs for Treatment ‑‑ 633
Did Not Know How or Where to Get Treatment ‑‑ 876
Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to ‑‑ 646
No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to ‑‑ 214
Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times that Worked for Them ‑‑ 472
Did Not Have Enough Time for Treatment ‑‑ 1,145
Worried That Information Would Not Be Kept Private ‑‑ 826
Worried about What People Would Think or Say if They Got Treatment ‑‑ 899
Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children ‑‑ 727
Not Ready to Start Treatment ‑‑ 1,469
Not Ready to Stop or Cut Back Using Drugs or Alcohol ‑‑ 1,442
Thought They Should Have Been Able to Handle Their Drug or Alcohol Use on Their Own ‑‑ 1,766
Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment ‑‑ 284
Thought They Would Be Forced to Stay in Rehab or Treatment against Their Will ‑‑ 385
Did Not Think Treatment Would Help Them ‑‑ 649
Thought No One Would Care if They Got Better ‑‑ 365

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.

NOTE: Respondents could indicate multiple reasons for not receiving substance use treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reasons for not receiving substance use treatment data were excluded.

NOTE: Respondents were classified as having a perceived unmet need for substance use treatment (SU Tx) if they did not receive SU Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for SU Tx were excluded.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.
260521
Table 5.37B – Detailed Reasons for Not Receiving Substance Use Treatment in Past Year: Among People Aged 18 or Older Who Did Not Receive Substance Use Treatment and Had a Perceived Unmet Need for Substance Use Treatment in Past Year; Percentages, 2024 and 2025
Reason for Not Receiving Substance Use Treatment Total
(2024)		 Total
(2025)
Thought It Would Cost Too Much ‑‑ 39.8
Did Not Have Health Insurance Coverage for Drug or Alcohol Use Treatment ‑‑ 28.0
Health Insurance Would Not Pay Enough of Costs for Treatment ‑‑ 31.1
Did Not Know How or Where to Get Treatment ‑‑ 39.7
Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to ‑‑ 30.6
No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to ‑‑ 10.3
Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times that Worked for Them ‑‑ 21.7
Did Not Have Enough Time for Treatment ‑‑ 52.5
Worried That Information Would Not Be Kept Private ‑‑ 37.8
Worried about What People Would Think or Say if They Got Treatment ‑‑ 41.0
Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children ‑‑ 33.4
Not Ready to Start Treatment ‑‑ 67.3
Not Ready to Stop or Cut Back Using Drugs or Alcohol ‑‑ 66.5
Thought They Should Have Been Able to Handle Their Drug or Alcohol Use on Their Own ‑‑ 80.4
Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment ‑‑ 13.0
Thought They Would Be Forced to Stay in Rehab or Treatment against Their Will ‑‑ 17.6
Did Not Think Treatment Would Help Them ‑‑ 29.9
Thought No One Would Care if They Got Better ‑‑ 16.7

* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues.

NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.

NOTE: Respondents could indicate multiple reasons for not receiving substance use treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reasons for not receiving substance use treatment data were excluded.

NOTE: Respondents were classified as having a perceived unmet need for substance use treatment (SU Tx) if they did not receive SU Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for SU Tx were excluded.

NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.

Definitions: Measures and terms are defined in Appendix A.

Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

▲ TOP TOC